Synergistic pesticidal compositions and methods for delivery of active ingredients
Synergistic pesticide compositions with C6-C10 aliphatic acids enhance pest control efficacy, addressing toxicity and resistance issues while reducing chemical pesticide use, achieving efficient and environmentally friendly pest management.
Patent Information
- Application Number
- KR1020257004434
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-11-14
- Filing Date
- 2018-09-29
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2038-09-29
AI Technical Summary
There is a need for environmentally safe and effective pesticides that minimize the use of chemical formulations while maintaining or enhancing pest control efficacy, as chemical pesticides are toxic, persist in the environment, and face issues with resistance and inefficiency.
Synergistic pesticide compositions comprising pesticide active ingredients and C6-C10 unsaturated or saturated aliphatic acids or their agriculturally suitable salts, with specific weight-based concentration ratios, to enhance pest control efficacy.
The synergistic compositions achieve effective pest control with reduced pesticide use, minimizing environmental impact and overcoming resistance issues, with FIC index values indicating significant growth inhibition.
Smart Images

Figure 112025015640311-PAT00123_ABST
Abstract
Description
Technology Field
[0001] Reference to related applications
[0002] The present application claims priority and benefit thereof to US provisional patent application No. 62 / 566269 filed September 29, 2017, with the title *SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS*; 62 / 580964 filed November 2, 2017; and 62 / 585827 filed November 14, 2017, all of which are incorporated herein by reference in their entirety.
[0003] Technology field
[0004] Embodiments of the present invention relate to compositions and methods for increasing the efficacy of pesticide compositions. More specifically, some embodiments relate to synergistic pesticide compositions and methods for delivering pesticide active ingredients. Some embodiments of the present invention relate to compositions and methods for increasing the efficacy of fungicides. Some embodiments of the present invention relate to compositions and methods for increasing the efficacy of nematicides. Some embodiments of the present invention relate to compositions and methods for increasing the efficacy of insecticides. Further embodiments of the present invention relate to methods for enhancing the activity of pesticide active ingredients in pesticide compositions. Background Technology
[0005] Pesticides, including fungicides, herbicides, nematicides, and insecticides, are important compositions for use in domestic, agricultural, industrial, and commercial environments to provide, for example, control of unwanted pests and / or pathogens. Providing effective pest control is critical in many of these environments because, if left uncontrolled, pests and / or other pathogens can cause loss and / or destruction of crops or other plants, or harm animals, humans, or other beneficial or desirable organisms. There remains a need for environmentally safe and effective pesticides, including fungicides, nematicides, and insecticides; compounds that enhance the efficacy of pesticides, including fungicides, nematicides, and insecticides; and methods to enhance the efficacy of pesticides, including fungicides, nematicides, and insecticides, so that pesticides can be used in a more environmentally safe and effective manner.
[0006] In agricultural environments, various plant pests—such as insects, worms, nematodes, fungi, and plant pathogens like viruses and bacteria—are known to cause significant damage to seeds, as well as ornamental and crop plants. While chemical pesticides have been commonly used, many of them are expensive, potentially toxic to humans, animals, and / or the environment, and can persist for a long time after application. Therefore, using the smallest possible amount of chemical pesticides while continuing to control pest growth to maximize crop yields is typically beneficial for farmers, consumers, and the surrounding environment. The use of chemical pesticides is also increasingly leading to increased resistance to certain pesticides by pest organisms, resulting in reduced effectiveness, the need for larger doses of pesticide chemicals, or even the failure of certain types of pesticides as viable control agents. Consequently, many chemical pesticides are being phased out or their use is being restricted.
[0007] To attempt to reduce the toxicity, health, and environmental risks associated with the use of chemical pesticides, the use of natural or biologically derived pesticide compounds instead of certain chemical pesticides has been proposed. However, some natural or biologically derived pesticides have proven to be less effective or inconsistent in performance compared to competing chemical pesticides, which has limited their adoption as control agents in the pesticide market.
[0008] Therefore, there remains a need to provide improved pesticides and pesticide compositions that enable effective, economical, and environmentally and ecologically safe control of insect, plant, fungal, nematode, mollusk, mite, viral, and bacterial pests. Specifically, there remains a need to provide pesticide compositions that preferably minimize the amount of pesticide formulation or active ingredient required to achieve a desired or acceptable level of pest control upon use.
[0009] Therefore, to provide the desired pest control performance upon use, there is still a need to provide synergistic pesticide compositions that preferably minimize the use of pesticide formulations or active ingredients through synergistic efficacy. However, large-scale experimental drug combination studies in non-agricultural fields have found that synergistic combinations of drug pairs are extremely complex and rare, with the probability of finding a synergistic drug pair being only 4 to 10% [Yin et al., PLOS 9:e93960 (2014); Cokol et al., Mol. Systems Biol. 7:544 (2011)]. Indeed, a systematic screening of approximately 120,000 two-component drug combinations based on the referenced drugs found less than 10% synergistic pairs, as well as only 5% synergistic two-component pairs, for the triazole fungicide compound fluconazole associated with a certain azole agricultural fungicide compound [Borisy et al., Proc. Natl Acad. Sci. 100:7977-7982 (2003)].
[0010] The foregoing examples of related technology and limitations associated therewith are intended to be exemplary and not exclusive. Other limitations of related technology will become apparent to those skilled in the art when considering the present disclosure.
[0011] In one embodiment according to the present disclosure, a synergistic pesticide composition is provided comprising: a pesticide active ingredient; and a C6-C10 unsaturated aliphatic acid (including unsaturated C6, C7, C8, C9, or C10 aliphatic acids) or an agriculturally suitable salt thereof, wherein the C6-C10 unsaturated aliphatic acid comprises at least one unsaturated CC bond, and the ratio of the weight-based concentrations of the pesticide active ingredient and the C6-C10 saturated or unsaturated aliphatic acid or the agriculturally suitable salt thereof is about 1:5000 to 5000:1, more specifically about 1:2000 to 2000:1. In another embodiment, a pesticide active ingredient; A synergistic pesticide composition is provided comprising a C6-C10 saturated aliphatic acid (including saturated C6, C7, C8, C9, or C10 aliphatic acids) or an agriculturally suitable salt thereof, wherein the ratio of the weight-based concentrations of the pesticide active ingredient and the C6-C10 saturated aliphatic acid or the agriculturally suitable salt thereof is about 1:5000 to 5000:1, more specifically about 1:2000 to 2000:1. Also, in another embodiment, a synergistic pesticide composition is provided comprising a pesticide active ingredient; and a C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof, wherein the ratio of the weight-based concentrations of the pesticide active ingredient and the C11 unsaturated or saturated aliphatic acid or the agriculturally suitable salt thereof is about 1:5000 to 5000:1, more specifically about 1:2000 to 2000:1. Also, in a further embodiment, a pesticide active ingredient; A synergistic pesticide composition comprising a C12 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof is provided, wherein the ratio of the weight-based concentrations of the pesticide active ingredient and the C12 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof is about 1:5000 to 5000:1, more specifically about 1:2000 to 2000:1.
[0012] In a further embodiment, a method is provided for synergistically enhancing the pesticide activity of at least one pesticide active ingredient suitable for controlling at least one target pest organism, the method comprising: providing at least one pesticide active ingredient that is active against said at least one target pest organism; providing a synergistic pesticide composition by adding to said pesticide active ingredient a synergistically effective concentration of at least one C6-C10 unsaturated aliphatic acid containing at least one unsaturated CC bond, or an agriculturally acceptable salt thereof; and controlling said at least one target pest organism by applying said synergistic pesticide composition at a pesticide-effective concentration. In another embodiment, instead of a C6-C10 unsaturated aliphatic acid, a C6-C10 saturated aliphatic acid or an agriculturally suitable salt thereof may be provided to provide the synergistic pesticide composition. Also in another embodiment, a C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may be provided to provide the synergistic pesticide composition. Additionally, in further embodiments, a C12 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may be provided to provide a synergistic pesticide composition. In some embodiments, the synergistic pesticide composition may comprise a C6-C10 unsaturated or saturated aliphatic acid or a biologically suitable salt thereof, wherein the salt comprises, for example, at least one of an agriculturally, aquatic, or mammal-suitable salt. In other embodiments, a C11 unsaturated or saturated aliphatic acid or a biologically suitable salt thereof, or a C12 unsaturated or saturated aliphatic acid or a biologically suitable salt thereof may be provided.
[0013] In another embodiment according to the present disclosure, a pesticide composition is provided comprising one or more pesticide formulations; and one or more unsaturated C6-C10 aliphatic acids having at least one unsaturated CC link or an agriculturally suitable salt thereof. In some other embodiments, a pesticide composition is provided comprising one or more pesticide formulations and one or more saturated C6-C10 aliphatic acids or an agriculturally suitable salt thereof. In some embodiments, one or more saturated or unsaturated C6-C10 aliphatic acids are present in a weight-based concentration ratio of about 1:5000 to 5000:1, more specifically about 1:2000 to 2000:1, which each produce a synergistic effect on the pesticide activity of the pesticide composition compared to the pesticide activity of the pesticide formulation alone and are synergistically active. In some such embodiments, a C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may be provided. In some additional such embodiments, a C12 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may be provided.
[0014] In a further embodiment, a method is provided for synergistically enhancing the pesticide activity of at least one pesticide active ingredient suitable for controlling at least one target pest organism, the method comprising: providing at least one pesticide active ingredient that is active against said at least one target pest organism; providing a synergistic pesticide composition by adding at least one unsaturated or saturated C6-C10 aliphatic acid or an agriculturally acceptable salt thereof at a synergistically effective concentration; mixing said synergistic pesticide composition with at least one formulation ingredient comprising a surfactant to form a synergistic pesticide concentrate; diluting said synergistic pesticide concentrate with water to form a synergistic pesticide emulsion; and applying said synergistic pesticide emulsion at a pesticide-effective concentration and ratio to control said at least one target pest organism. In some of these embodiments, a C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may be provided. In some further of these embodiments, a C12 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may be provided.
[0015] In some embodiments, the synergistic pesticide composition is about 1:10,000 to 10,000:1, 1:5,000 to 5,000:1, 1:2,500 to 2,500:1, 1:1,500 to 1,500:1, 1:1,000 to 1,000, 1:750 to 750:1, 1:500 to 500:1, 1:400 to 400:1, 1:300 to 300:1, 1:250 to 250:1, 1:200 to 200:1, 1:150 to 150:1, 1:100 to 100:1, 1:90 to 90:1, 1:80 to 80:1, 1:70 to 70:1, 1:60 to 60:1, 1:50 to 50:1, 1:40 to 40:1, 1:30 to 30:1, 1:25 to 25:1, 1:20 to 20:1, 1:15 to 15:1, 1:10 to 10:1, 1:9 to 9:1. It may comprise a weight-based concentration ratio of at least one of the pesticide active ingredient and at least one of the saturated or unsaturated C6-C10 aliphatic acid or an agriculturally suitable salt thereof, among 1:8 to 8:1, 1:7 to 7:1, 1:6 to 6:1, 1:5 to 5:1, 1:4 to 4:1, 1:3 to 3:1, 1:2 to 2:1, 1:1.5 to 1.5:1, and 1.25 to 1.25:1. In a specific embodiment thereof, the concentration ratio of the pesticide active ingredient and the at least one C6-C10 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof in the synergistic pesticide composition is advantageously selected to produce a synergistic effect against at least one target pest or pathogen. In some embodiments, the concentration ratio of the pesticide active ingredient(s) in the synergistic pesticide composition and at least one C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may advantageously be selected to produce a synergistic effect on at least one target pest or pathogen.In some additional embodiments, the concentration ratio of the pesticide active ingredient(s) in the synergistic pesticide composition and at least one C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof may advantageously be selected to produce a synergistic effect on at least one target pest or pathogen.
[0016] In some embodiments, the synergistic pesticide composition comprises a pesticide active ingredient and a C6-C10 unsaturated aliphatic acid comprising at least one of a trans-unsaturated CC bond and a cis-unsaturated CC bond. In further such embodiments, the C6-C10 unsaturated aliphatic acid comprises at least one of trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, and trans-9 unsaturated bonds. Also, in another embodiment, a synergistic pesticide composition is provided comprising a pesticide active ingredient and a C6-C10 unsaturated aliphatic acid comprising at least one of cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, and cis-9 unsaturated bonds. In some of these embodiments, the pesticide composition comprises a C11 unsaturated aliphatic acid or an agriculturally suitable salt thereof, which comprises at least one of trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, trans-9, trans-10, cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, cis-9, and cis-10 unsaturated bonds. In some additional embodiments, the pesticide composition comprises a C12 unsaturated aliphatic acid or an agriculturally suitable salt thereof, which comprises at least one of trans-2, trans-3, trans-4, trans-5, trans-6, trans-7, trans-8, trans-9, trans-10, trans-11, cis-2, cis-3, cis-4, cis-5, cis-6, cis-7, cis-8, cis-9, cis-10, and cis-11 unsaturated bonds. In some embodiments, the synergistic pesticide composition may comprise at least one C6-C10 saturated aliphatic acid, such as, for example, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, and decanoic acid. In some additional embodiments, the synergistic pesticide composition may additionally comprise at least one second C6-C10 saturated or unsaturated aliphatic acid.In some additional embodiments, the pesticide composition may additionally comprise at least one second C11 or C12 unsaturated or saturated aliphatic acid, or an agriculturally suitable salt thereof.
[0017] In some embodiments, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise a naturally occurring aliphatic acid, such as one that may be present in, extracted from, fractionated from, or derived from, for example, natural plant or animal material. In one such embodiment, at least one C6-10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in a plant extract or a fraction thereof. In another such embodiment, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in an animal extract or product, or a fraction thereof. In one such embodiment, at least one C6-C10 saturated or unsaturated alphatic acid may comprise a naturally occurring aliphatic acid contained in a plant oil extract, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts derived therefrom. In another such embodiment, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise a naturally occurring aliphatic acid contained in an animal extract or product, such as, for example, cow's milk, goat's milk, tallow, and / or cow or goat butter, or fractions or extracts thereof. In a specific embodiment, at least one C6-C10 saturated aliphatic acid may be provided in an extract or fraction of one or more plant oil extracts, such as coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts thereof. In some additional embodiments, the agrochemical composition may comprise at least one C11 or C12 saturated or unsaturated aliphatic acid provided in an extract or fraction of one or more plant or animal materials.
[0018] In some embodiments, the synergistic pesticide composition exhibits synergistic growth inhibition of at least one target pest organism. In some embodiments, the synergistic pesticide composition comprises a pesticide-effective concentration of a pesticide-active ingredient and one or more C6-C10 saturated or unsaturated aliphatic acids. In some additional embodiments, the synergistic pesticide composition comprises a pesticide-active ingredient and a synergistic concentration of one or more C6-C10 saturated or unsaturated aliphatic acids. In some embodiments, the synergistic pesticide composition has an FIC index (fractional inhibition concentration index value) of less than 1 according to growth inhibition analysis for growth inhibition of at least one target pest or pathogen organism. In some embodiments, the synergistic pesticide composition has an FIC index value of less than 0.75. In further embodiments, the synergistic pesticide composition has an FIC index value of 0.5 or less. In some of these embodiments, one or more saturated or unsaturated aliphatic acids may comprise a C11 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof. In some additional embodiments of this embodiment, one or more saturated or unsaturated aliphatic acids may comprise a C12 unsaturated or saturated aliphatic acid or an agriculturally suitable salt thereof.
[0019] In some embodiments, the pesticide active ingredient may comprise at least one of a chemical pesticide and a naturally derived pesticide oil or extract. In further embodiments, the pesticide active ingredient may comprise at least one of a fungicide, a nematicide, an insecticide, an acaricide, a herbicide, and a bactericidal agent.
[0020] In any of these embodiments, the synergistic pesticide composition may comprise one or more C6-C10 saturated or unsaturated aliphatic acids that may be linear or branched and have at least one carboxylic acid group. In some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids may comprise linear monocarboxylic acids. In some embodiments, the C6-C10 unsaturated aliphatic acid may comprise one or more cis and trans isomers. In some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids may be unsubstituted or substituted. In some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids may comprise unsaturated aliphatic acids that may be monounsaturated or polyunsaturated, i.e., containing one or more unsaturated carbon-carbon (CC) bonds, respectively. In some embodiments, one or more C6-C10 unsaturated aliphatic acids may comprise an unsaturated aliphatic acid having at least one of a trans-unsaturated CC bond, a cis-unsaturated CC bond, and a plurality of conjugated unsaturated CC bonds. In some such embodiments, one or more saturated or unsaturated aliphatic acids may comprise a C11 unsaturated or saturated aliphatic acid which may be linear or branched, substituted or unsubstituted, may comprise one or more cis and trans isomers, may be monounsaturated or polyunsaturated, or may comprise at least one of a trans-unsaturated CC bond, a cis-unsaturated CC bond, and a plurality of conjugated unsaturated CC bonds. In some additional embodiments of this embodiment, one or more saturated or unsaturated aliphatic acids may comprise a C12 unsaturated or saturated aliphatic acid that may be linear or branched, substituted or unsubstituted, may comprise one or more cis and trans isomers, may be monounsaturated or polyunsaturated, or may comprise at least one of a trans-unsaturated CC link, a cis-unsaturated CC link, and a plurality of conjugated unsaturated CC linkages.
[0021] In some additional embodiments, one or more C6-C10 (including C6, C7, C8, C9 or C10) saturated or unsaturated aliphatic acids may include at least one of trans-hexenic acid, cis-hexenic acid, hexa-dienoic acid, hexic acid, trans-hepteneic acid, cis-hepteneic acid, hepta-dienoic acid, hepteneic acid, trans-octenic acid, cis-octenic acid, octa-dienoic acid, octeneic acid, trans-noneneic acid, cis-noneneic acid, nona-dienoic acid, noninic acid, trans-deceneic acid, cis-deceneic acid, deca-dienoic acid, and dekinic acid. In another embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids may include at least one of hexa-dienoic acid, hexic acid, trans-hepteneic acid, cis-hepteneic acid, hepta-dienoic acid, hepteneic acid, trans-octenic acid, cis-octenic acid, octa-dienoic acid, octeneic acid, trans-noneneic acid, cis-noneneic acid, nona-dienoic acid, noninic acid, trans-deceneic acid, cis-deceneic acid, deca-dienoic acid, and deceneic acid. In some embodiments, one or more saturated or unsaturated aliphatic acids may include at least one of C11 or C12 unsaturated aliphatic acids, such as, for example, cis-undecenate, trans-undecanate, cis-dodecenoic acid, trans-dodecenoic acid, undeca-dienoic acid, dodeca-dienoic acid, undecinic acid, or dodeccinic acid.
[0022] In some additional embodiments, one or more C6-C10 (including C6, C7, C8, C9 or C10) saturated or unsaturated aliphatic acids may include at least one of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, and decanoic acid. In some embodiments, one or more saturated or unsaturated aliphatic acids may include at least one of undecanoic acid or dodecanoic acid.
[0023] In some embodiments, the synergistic pesticide composition may comprise one or more agriculturally suitable or acceptable salts of one or more C6-C10 saturated or unsaturated aliphatic acids. In one such embodiment, such agriculturally suitable or acceptable salts may comprise, for example, one or more of potassium, sodium, calcium, aluminum, other suitable metal salts, ammonium, and other agriculturally acceptable salts of one or more C6-C10 saturated or unsaturated aliphatic acids. In another embodiment, the synergistic pesticide composition may comprise one or more C6-C10 saturated or unsaturated aliphatic acids or biologically suitable salts thereof, wherein the salts comprise, for example, at least one of agriculturally, aquatic, or mammalian-suitable salts. In some embodiments, the pesticide composition may comprise one or more agriculturally suitable or acceptable salts of one or more C11 or C12 saturated or unsaturated aliphatic acids.
[0024] However, in some other embodiments, the synergistic pesticide composition may comprise a pesticide active ingredient and one or more C6-C10 saturated or unsaturated aliphatic acids, wherein the C6-C10 unsaturated aliphatic acid comprises at least one unsaturated CC bond and the weight-based concentration ratio of the pesticide active ingredient and the C6-C10 saturated or unsaturated aliphatic acid is about 1:5000 to 5000:1, more specifically about 1:2000 to 2000:1.
[0025] In one such embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids may exclude agriculturally acceptable salts or other salt forms of one or more C6-C10 saturated or unsaturated aliphatic acids. In a specific such embodiment, the synergistic pesticide composition may exclude salts for a desired application where acid forms of one or more C6-C10 saturated or unsaturated aliphatic acids may be desirable. In one such application, the accumulation of unwanted high concentrations of salt in some soils is known to be detrimental to soil productivity or fertility, for example, specifically in salt-sensitive soil applications. Therefore, in some embodiments, it may be specifically desirable to explicitly exclude salt forms of one or more C6-C10 saturated or unsaturated aliphatic acids.
[0026] In another embodiment, the synergistic pesticide composition may comprise a pesticide active ingredient and at least one C6-C10 saturated aliphatic acid, such as at least one of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, and decanoic acid. In an alternative embodiment, the synergistic pesticide composition may comprise a pesticide active ingredient and at least one C6-C10 unsaturated aliphatic acid, but may explicitly exclude 2,4-hexadienoic acid. In some of these embodiments, one or more saturated or unsaturated aliphatic acids may comprise a C11 unsaturated or saturated aliphatic acid. In some additional of these embodiments, one or more saturated or unsaturated aliphatic acids may comprise a C12 unsaturated or saturated aliphatic acid.
[0027] In some embodiments of the present disclosure, a synergistic pesticide composition may comprise at least one C6-C10 saturated or unsaturated aliphatic acid and at least one pesticide active ingredient selected from a list including the following:
[0028] A) Respiratory depressants selected from the following:
[0029] Qo Inhibitors of Complex III at the site: azoxystrobin (II-1), cumethoxystrobin, cumoxistrobin, dimoxistrobin (II-2), enestrobulin, phenaminestrobin, phenoxystrobin / flufenoxystrobin, fluoxastrobin (II-3), cresoxim-methyl (II-4), metominostrobin, orysastrobin (II-5), picoxistrobin (II-6), pyraclostrobin (II-7), piramethostrobin, piraoxystrobin, triploxistrobin (II-8), 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylate methyl ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneamino-oxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, Pyribencarb, triclopyricarb / chlorodinecarb, famoxadone, phenamidon;
[0030] Q i Inhibitors of Complex III at the site: cyazopamide, amisolbromine, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)-amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarboniroxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenyl-methyl)-1,5-dioxonan-7-yl 2-methylpropanoate;
[0031] Inhibitors of Complex II: Benodanil, Benzobindiflupir (II-9), Bixafen (II-10), Boscalid (II-11), Carboxin, Fenflufen, Flupiram (II-12), Flutolanil, Fluxapiroxad (II-13), Furamepir, Isofetamide, Isopirazam (II-14), Mepronil, Oxycarboxyl, Fenflufen (II-15), Penthiopyrad (II-16), Cedaxan (II-17), Teclophthalam, Tifluzamide, N-(4'-Trifluoromethylthiobiphenyl-2-yl)-3-Difluoromethyl-1-methyl-1H-pyrazol-4-Carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindane-4-yl)pyrazol-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindane-4-yl)pyrazol-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindane-4-yl)pyrazol-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindane-4-yl)pyrazol-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindane-4-yl)pyrazole-4-carboxamide, N-(7-fluoro-1,1,3-trimethylindane-4-yl)-1,3-dimethylpyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide;
[0032] Other respiratory depressants: diflumethorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromet-ylpyridine-2-yloxy)-phenyl]-ethyl}-amine; vinapractil, dinobutone, dinocap, fluazinam (II-18); ferimzone; pentene salts such as pentene acetate, pentene chloride, or pentene hydroxide; amethoxtradine (II-19); and silthiopham;
[0033] B) Sterol biosynthesization inhibitors (SBI fungicides) selected from the following:
[0034] C14 demethylase inhibitors (DMI fungicides): azaconazole, bitertanol, bromuconazole, cyproconazole (II-20), difenoconazole (II-21), diniconazole, diniconazole-M, epoxyconazole (II-22), fenbuconazole, fluquinconazole (II-23), flucilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole (II-24), miclobutanil, oxpoconazole, paclobutrazol, fenconazole, propiconazole (II-25), prothioconazole (II-26), simeconeazole, tebuconazole (II-27), tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole; Imazalil, pefurazoeate, prochloraz, triflumizole; fenarimol, nuarimol, pyrifenox, triporin, [3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)isoxazole-4-yl]-(3-pyridyl)methanol;
[0035] Delta-14-reductase inhibitors: Aldimorph, Dodemorph, Dodemorph acetate, Fenpropimorph, Tridemorph, Fenpropidine, Piperaline, Spiroxamine;
[0036] 3-keto reductase inhibitor: fenhexamide;
[0037] C) Nucleic acid synthesis inhibitors selected from the following:
[0038] Phenylamide or acyl amino acid fungicides: Benalaxil, Benalaxil-M, Chiralaxil, Metalaxil, Metalaxil-M (Mefenoxam)(II-38), Opulese, Oxadixil;
[0039] Other nucleic acid inhibitors: hymexazole, octyllinone, oxolinic acid, burimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidine-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidine-4-amine;
[0040] D) Cell division and cytoskeleton inhibitors selected from the following:
[0041] Tubulin inhibitors: Benomil, Carbendazim, Fuberidazole, Thiabendazole, Thiophanate-methyl(II-39); 5-chloro-7-(4-methylpiperidine-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine
[0042] Other cell division inhibitors: diethofencarb, ethaboxam, phencyclone, fluopicolide, zoxamide, metrafenone(II-40), pyriophenone;
[0043] E) Amino acid and protein synthesis inhibitors selected from the following:
[0044] Methionine synthesis inhibitors (anilino-pyrimidine): cyprodinyl, mepanipyrim, pyrimetanil (II-41);
[0045] Protein synthesis inhibitors: Blasticidin-S, Kasugamycin, Kasugamycin hydrochloride-hydrate, Mildiomycin, Streptomycin, Oxytetracycline, Polyoxin, Validamycin A;
[0046] F) Signal transduction inhibitors selected from the following:
[0047] MAP / histidine kinase inhibitors: fluoroimide, iprodione, procymidone, vinclozoline, fenpiclonil, fludioxonil;
[0048] G protein inhibitor: Quinoxifene;
[0049] G) Lipid and membrane synthesis inhibitors selected from the following:
[0050] Phospholipid biosynthesization inhibitors: edifenphos, iprobenphos, pyrazofos, isoprothiolane; propamocarb, propamocarb-hydrochloride;
[0051] Lipid peroxidation inhibitors: dichloran, quintozene, technagen, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
[0052] Phospholipid biosynthesis and cell wall deposition: dimethomorph(II-42), flumorph, mandipropamide(II-43), pyrimorb, ventiavalicarb, iprovalicarb, valifenalate, N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl)carbamic acid-(4-fluorophenyl)ester;
[0053] Acid amide hydrolase inhibitor: oxathiapiproline;
[0054] H) Multisite-acting inhibitors selected from the following: Inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride (II-44), basic copper sulfate, sulfur;
[0055] Thio- and dithiocarbamates: Perbam, Mancozeb (II-45), Maneb, Metam, Metiram (II-46); Propineb, Tiram, Zineb, Ziram;
[0056] Organochlorine compounds: anilazine, chlorothalonyl(II-47), kaftapol, kaftan, polpet, dichlorofluanid, dichlorophen, hexachlorobenzene, pentachlorophenol and its salts, phthalides, tolylfluanid, N-(4-chloro-lo-2-nitro-phenyl)-N-ethyl-4-methylbenzenesulfonamide;
[0057] Guanidine and others: guanidine, dodine, dodine free base, guaxatin, guaxatin-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesylate), dithianone, 2,6-dimethyl-1H,5H-[1,4]dti-no[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraone(II-48);
[0058] I) Cell wall synthesis inhibitors selected from the following:
[0059] Glucan synthesis inhibitors: validamycin, polyoxin B;
[0060] Melanin synthesis inhibitors: Piroquilon, Tricyclazole, Carpropamide, Dicyclomet, Fenoxanil;
[0061] J) Plant defense inducers selected from the following:
[0062] Asybenzolar-S-methyl, probenazole, isothianil, thiadinyl, prohexadione-calcium; fosetyl, fosetyl-aluminum, phosphoric acid and salts thereof (II-49);
[0063] K) Unknown mode of action selected from the following: bronopol, kinomethionat, cyflufenamide, cymoxanil, dazomet, debacarb, diclomezine, dipenzoquart, dipenzoquart-methylsulfate, diphenylamine, fenpyrazamine, flumetover, flusulfamide, flutianil, metasulfocarb, nitrapyrin, nitrotal-isopropyl, oxathiapiproline, tolprocarb, 2-[3,5-bis(difluoromethyl)-1H-pyrazole-1-yl]-1-[4-(4-{5-[2-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazole-3-yl}-1,3-thiazole-2-yl)piperidine-1-yl]ethanone, 2-[3,5-bis-(difluoromethyl)-1H-pyrazole-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-in-1-yl-oxy)phenyl]-4,5-dihydro-1,2-oxazole-3-yl}-1,3-thiazole-2-yl)piperidin-1-yl]-ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazole-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazole-3-yl}-1,3-thiazole-2-yl)piperidin-1-yl]ethanone, auxin-copper, proquinazide, tebufloquine, teclophthalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclo-propylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenylacetamide, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methylformamidine, N'-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylformamidine, N'-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine, N'-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl Formamidine, methoxyacetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinoline-4-yl ester, 3-[5-(4-meth-ylphenyl)-2,3-dimethyl-isoxazolidine-3-yl]-pyridine,3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine(pyridoxazole), N-(6-methoxy-pyridine-3-yl)cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidine-2-yl)-2-methyl-1H-benzimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazole-5-yl]-2-prop2-inyloxy-acetamid, ethyl(Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, tert-butyl N-[6-[[(Z)-[(1-methyltetrazole-5-yl)-phenyl-methylene]-amino]oxymethyl]-2-pyridyl]carbamate, pentyl N-[6-[[(Z)-[(1-methyltetrazole-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-dipro-fluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinoline-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinoline-1-yl)quinoline;,
[0064] L) Antifungal biopesticides selected from the following: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus pumilus (II-50), Bacillus subtilis (II-51), Bacillus subtilis var. amyloliquefaciens (II-52), Candida oleophila I-82, Candida saitoana, Clonostachys rosea f. catenulata, and Gliocladium catenulatum. Named, Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Metschnikowia fructicola, Microdochium dimerum, Phlebiopsis gigantean, Pseudozyma flocculosa, Pythium oligandrum DV74, Reynoutria sachlinensis, Talaromyces flavus V117b, Trichoderma asperellum SKT-1, T. T. atroviride LC52, T. harzianum T-22, T. harzianum TH 35, T. harzianum T-39; T. harzianum and T. viride, T.T. harzianum ICC012 and T. viride ICC080; T. polysporum and T. harzianum; T. stromaticum, T. virens GL-21, T. viride, T. viride TV1, Ulocladium oudemansii HRU3;.
[0065] M) Growth regulators selected from the following: abscisic acid, amidochlor, anthimidol, 6-benzylaminopurine, brassino-ride, butralin, chlormequart (chlormequart chloride), choline chloride, cyclanilide, daminozide, dicegulaq, dimethipine, 2,6-dimethylfuridine, ethephon, plumetralin, flurprimidol, fluthiacet, forchlorofenurone, gibberelate, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquart (mepiquart chloride) (II-54), naphthaleneacetic acid, N-6-benziladenine, paclobutrazol, prohexadione (prohexadione-calcium, II-55), prohydrojasmon, tidiazuron, triapentenol, Tributyl phosphotrithioate, 2,3,5-tri-iodobenzoic acid, Trinex-apat-ethyl and uniconazole;
[0066] N) Herbicides selected from the following:
[0067] Acetamide: Acetochlor, Alachlor, Butachlor, Dimetachlor, Dimethenamide, Flufenacet, Mefenacet, Me-Tolachlor, Metazachlor, Napropamide, Naproanilide, Fetoxamide, Pretilachlor, Propachlor, Tenylchlor;
[0068] Amino acid derivatives: Villanaphos, glyphosate, glufosinate, sulfosate;
[0069] Aryloxyphenoxypropionate: Clodinapop, Cyhalopov-butyl, Fenoxaprop, Fluazipov, Haloxipov, Metamifov, Propakizapov, Quizalopov, Quizalopov-P-Tepuril;
[0070] Bipyridyl: diquart, paraquart;
[0071] (Thio)Carbamates: Asulam, Butylate, Carbetamide, Desmedipam, Dimepiperate, Eftam (EPTC), Esprocarb, Molineate, Orbencarb, Fenmedipam, Prosulfocarb, Piributicarb, Thiobencarb, Trialate;
[0072] Cyclohexanedione: Butroxidim, Cletodim, Cycloxidim, Propoxydim, Cetoxydim, Tepraloxidim, Tralcoccidim;
[0073] Dinitroaniline: Benfluralin, Ethalfluralin, Oryzalin, Pendimethalin, Prodiamine, Trifluralin;
[0074] Diphenyl ether: acifluorophene, acloniphene, bifenox, diclopoff, ethoxyphene, fomesafen, lactophene, oxyfluorophene; -hydroxybenzonitrile: botoxinil, diclobenil, ioxinil;
[0075] Imidazolinone: Imazametabenz, Imazamox, Imazafic, Imazapyr, Imazaquin, Imazetapr;
[0076] Phenoxyacetic acid: Clomeprop, 2,4-Dichlorophenoxyacetic acid(2,4-D), 2,4-DB, Dichloroprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;
[0077] Pyrazines: Chloridazone, Flufenpyr-ethyl, Fluthiacet, Norflurazone, Pyridate;
[0078] Pyridine: Aminopyralide, Clopyralide, Diflufenican, Dithiopyr, Fluridone, Fluroxipyr, Picloram, Picolinafene, Thiazopyr;
[0079] Sulfonyl Urea: Amidosulfuron, Azimsulfuron, Bensulfuron, Chlorimuronetyl, Chlorsulfuron, Xinosulfuron, Cyclosulfamuron, Ethoxysulfuron, Plazasulfuron, Flucetosulfuron, Flupyrsulfuron, Foramsulfuron, Halosulfuron, Imazosulfuron, Iodosulfuron, Mesosulfuron, Metazosulfuron, Metsulfuron-Methyl, Nicosulfuron, Oxasulfuron, Primyulfuron, Prosulfuron, Pyrazosulfuron, Limsulfuron, Sulfometuron, Sulfosulfuron, Tifensulfuron, Triasulfuron, Trivenuron, Trifloxysulfuron, Triflusulfuron, Tritosulfuron, 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazine-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidine-2-yl)urea;
[0080] Triazines: Ametrin, Atrazine, Cyanazine, Dimetametrin, Ethiozine, Hexazinone, Metamitron, Metribuzine, Promethrin, Simazine, Terbutylazine, Terbutrin, Triaziflam;
[0081] Urea: Chlorotolurone, Daimurone, Diurone, Fluometurone, Isoproturone, Linurone, Metabenzthiazurone, Tebutiurone;
[0082] Other acetolactate synthase inhibitors: bispyrivac-sodium, chloransulam-methyl, diclosulam, florasulam, flucarbazone, flumethulam, methosulam, ortho-sulfamurone, phenoxulam, propoxycarbazone, piribam-benz-propyl, piribenzoxime, pyriphthalide, pyriminovac-methyl, pirimilpan, pyritiovac, piroxasulfone, p-roxulam;
[0083] Other herbicides: Amicarbazone, Aminotriazole, Anilofos, Beflubutamide, Benazolin, Bencarbazone, Benfluresate, Benzofenaf, Bentazone, Benzobicyclone, Bicyclopyron, Bromasil, Bromobutide, Butafenacil, Butamifos, Capenstrol, Carpentrazone, Cinidone-ethyl, Chlortal, Sinmethylene, Clomazone, Coumaluron, Cyprosulfa-mide, Dicamba, Difenzoquart, Diflufenzopyr, Dracxlera monoceras, Endothal, Ethofumesate, Ethobenzanide, Phenoxasulfone, Pentrazamide, Flumichlorac-pentyl, Flumioxazine, Flufoxam, Flurochloridone, Flurtamone, Indanophan, Isoxaben, Isoxaflutol, Renacil, Propanyl, Propizamide, Quinchlorac, Quinmerac, Mesotrione, Methyl arsonic acid, Naphthalam, Oxadiargyll, Oxadiazone, Oxaziclomephon, Pentoxazone, Pinoxadene, Pyraclonil, Piraflufen-ethyl, Pyrasulphotol, Pyrazoxifen, Pyrazolinate, Quinoclamin, Safluphenacil, Sulcotrione, Sulfentrazone, Terbacyl, Tefuryltrione, Tembotrone, Tiencarbazone, Topramesone, (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidine-1-yl)-phenoxy]-pyridine-2-yloxy)-ethyl acetate, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid Methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazine-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester;
[0084] O) Insecticides selected from the following:
[0085] Organic (thio)phosphates: Acepate, azamethifos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfonate, ethion, fenitrothion, pention, isoxathion, malathion, metamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemetone-methyl, paraoxone, parathion, pentoate, fossalon, phosmet, phos-pamidone, phorate, foxim, pyrimifos-methyl, propenophos, prothiophos, sulfophos, tetrachlorbinphos, terbuphos, triazophos, trichlorophon;
[0086] Carbamates: Alanicarb, Aldicarb, Bendiocarb, Benfuracarb, Carbaryl, Carbofuran, Carbosulfan, Phenox-Icarb, Furatiocarb, Methiocarb, Methomyl, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Triazamate;
[0087] Pyrethroids: Allethrin, Bifenthrin, Cyfluthrin, Cyhalothrin, Cyfenothrin, Cypermethrin, Alpha-Cypermethrin, Beta-Cypermethrin, Zeta-Cypermethrin, Deltamethrin, Esfenvalerate, Ethofenprox, Fenpropartrin, Fen-valerate, Imiprothrin, Lambda-Cyhalothrin, Permethrin, Prallethrin, Pyrethrin I and II, Resmethrin, Silafluophene, Tau-Fluvalinate, Tefluthrin, Tetramethrin, Tralomethrin, Transfluthrin, Profluthrin, Dimefluthrin;
[0088] Insect growth regulators: a) Chitin synthesis inhibitors: Benzoyl ureas: Chlorfluazurone, cyramazine, dipro-lubenzurone, flucycloxurone, flufenoxurone, hexaflumurone, lufenurone, novaluone, teflubenzurone, triflumurone; buprofezin, diophenolan, hexitiazox, ethoxazole, clopentazine; b) Ecdysone antagonists: Halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) Juvenoids: Piriproxifene, metoprene, phenoxycarb; d) Lipid biosynthesis inhibitors: Spirodiclofen, spiromesifen, spirotetramat;
[0089] Nicotinic receptor agonist / antagonist compounds: Clothianidin, Dinotefuran, Flupiradifuron, Imidacloprid, Thiamethoxam, Nitenpyram, Acetamiprid, Thiacloprid, 1-2-chloro-thiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1,3,5]triazinan;
[0090] GABA antagonist compounds: endosulfan, etiprol, fipronil, vanilliprol, pirafluprol, pyriprol, 5-amino-1-(2,6-dichloro-4-methyl-phenyl)-4-sulfinamoyl-1H-pyrazole-3-carbothiosamide;
[0091] Mitochondrial electron transport inhibitors (METI) I Salvages: Phenazaquin, Pyridaben, Tebufenpyrad, Tolfenpyrad, Flufenerim;
[0092] METI II and III compounds: acequinosyl, fluacyprim, hydramethylone;
[0093] Uncoupler: Chlorphenapyr;
[0094] Oxidative phosphorylation inhibitors: cyclohexatin, diapentiurone, fenbutatin oxide, proparzite;
[0095] Molting inhibitory compound: Cryomazine;
[0096] Mixed-function oxidase inhibitor: Piperonyl butoxide;
[0097] Sodium channel blockers: indoxacarb, metaflumizone;
[0098] Ryanodine receptor inhibitors: chlorantraniliprol, cyantraniliprol, fluben-diamide, N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanilidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4-sulfanilidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanilidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazol-3-car-boxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanilidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazol-3-carboxamide; N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanilidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazol-3-carboxamide; N-[4,6-di-bromo-2-[(di-2-propyl-lambda-4-sulfanyl-idene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoro-omethyl)pyrazol-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazol-3-carboxamide; N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazol-3-carboxamide;
[0099] Others: Benclotiaz, Biphenazate, Cartap, Flonicamide, Pyridalil, Pimetrozine, Sulfur, Thiocyclam, Cyenopyrafen, Flupyrazophos, Cyflumethofen, Amidoflumeth, Imisiahphos, Bistriflurone, Pyrifluquinazone, 1,1'-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]-methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]cyclopropaneacetic acid ester; fluensulfone, fluoroalkenyl thioether; and
[0100] P) Ribonucleic acid (RNA), and related compounds including double-stranded RNA (dsRNA), microRNA (miRNA) and small interfering RNA (siRNA); bacteriophage.
[0101] In some of these embodiments, the synergistic pesticide composition may comprise one or more pesticide active ingredients, such as those selected from the above list, and one or more C11 unsaturated or saturated aliphatic acids or agriculturally acceptable salts thereof. In some additional of these embodiments, the synergistic pesticide composition may comprise one or more pesticide active ingredients, such as those selected from the above list, and one or more C12 unsaturated or saturated aliphatic acids or agriculturally acceptable salts thereof.
[0102] In some embodiments, a synergistic pesticide composition may be provided comprising at least one pesticide-active oil selected from neem oil, caranza oil, clove oil, clove leaf oil, peppermint oil, spearmint oil, mint oil, cinnamon oil, thyme oil, oregano oil, rosemary oil, geranium oil, lime oil, lavender oil, anise oil, lemongrass oil, tea tree oil, apricot kernel oil, bergamot oil, carrot seed oil, cedar leaf oil, citronella oil, clove bud oil, coriander oil, coconut oil, eucalyptus oil, evening primrose oil, fennel oil, ginger oil, grapefruit oil, nootcarton(+), grapeseed oil, lavender oil, marjoram oil, pine oil, Scotch pine oil, and / or garlic oil and / or components, derivatives and / or extracts of one or more pesticide-active natural oils, or combinations thereof. In some additional embodiments, a synergistic pesticide composition may be provided comprising additional active ingredients in addition to one or more major pesticide active ingredients, such additional active ingredients may comprise one or more additional efficacies and / or synergistic effects on the pesticide efficacy of the composition, such as but not limited to adjuvants, synergists, agents, activators, or combinations thereof. In one such embodiment, such additional active ingredients may optionally comprise naturally occurring compounds or extracts or derivatives thereof.In another embodiment, the pesticide active ingredient is, for example, at least one organic, certified organic, or U.S. Department of Agriculture ("USDA") National Organic Program compliant ("NOP compliant"), such as being included in the U.S. Environmental Protection Agency ("US Environmental Protection Agency") FIFRA 25b, the list of ingredients published by the U.S. EPA in December 2015 titled "Active Ingredients Eligible for Minimum Risk Pesticide Products," the U.S. EPA FIFRA 4a list published in August 2004 titled "List 4A - Minimal Risk Inert Ingredients," or the U.S. EPA FIFRA 4b list published in August 2004 titled "List 4B - Other ingredients for which EPA has sufficient information," or organic It may be listed by the Organic Materials Review Institute ("Listed by OMRI") or contain natural pesticide active ingredients.
[0103] In some embodiments, the pesticide active ingredient may comprise at least one of neem oil, caranza oil, and extracts or derivatives thereof. In further exemplary embodiments, the pesticide active ingredient may comprise at least one extract or active ingredient of neem oil or caranza oil, such as but not limited to azadirachtin, azadiradione, azadirone, nimbin, nimbidin, salanin, deacetylsalanin, salanol, maliantriol, gedunin, carangin, fontamoll, or derivatives thereof. Brief explanation of the drawing
[0104] Exemplary embodiments are illustrated in the reference drawings. The embodiments and drawings disclosed herein are intended to be regarded as exemplary rather than limiting. FIG. 1 is a general carbonyl alkene structure associated with an exemplary C6-C10 saturated or unsaturated aliphatic acid, or an agriculturally acceptable salt thereof, according to an embodiment of the present disclosure. (1) , (2) , (3) , (4) , (5) , (6) and (7) . FIG. 2 illustrates an exemplary 96-well microtiter plate showing color transitions of resazurin dyes between colors indicating the absence and presence of growth of representative pests or pathogens according to a synergistic growth inhibition analysis according to an embodiment of the present disclosure. FIGS. 3 to 5 illustrate, according to an embodiment of the present invention, the survival rates over time for an in vitro test on a modified McMorran artificial diet, in which the treatment alone of Pylon® insecticide (containing chlorfenapyr as the active ingredient) and an exemplary unsaturated aliphatic acid (and salt) is compared with the corresponding survival rates for a treatment using a synergistic pesticide composition in which Pylon® insecticide is combined with each of the exemplary unsaturated aliphatic acid (and salt) at three concentrations (shown in FIGS. 3, 4, and 5, respectively). Trichoplushia ni ( Trichoplusia ni Plot the observed survival rate (percentage of original insects still alive) for )(southern silver-patterned moth larvae). Specific details for implementing the invention
[0105] Detailed description of some implementation examples
[0106] Throughout the following detailed description, specific details are presented to provide a more complete understanding to those skilled in the art. However, to avoid making the disclosure unnecessarily obscure, well-known elements may not be shown or described in detail. Accordingly, the description and drawings should be considered illustrative rather than restrictive.
[0107] definition
[0108] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as generally understood by a person skilled in the art to which this invention pertains. Although methods and materials similar or equivalent to those described herein may be used in the practice or testing of this invention, suitable methods and materials are described herein.
[0109] All applications, publications, patents, and other references and citations cited herein are incorporated by reference in their entirety. In the event of a conflict, the specification containing the definitions shall prevail.
[0110] As used herein, the singular forms "a," "and," and "the" include plural referents unless the context clearly indicates otherwise.
[0111] As used herein, all numeric values or numeric ranges include integers within such ranges and parts of values or integers within such ranges, unless the context clearly indicates otherwise. Thus, for example, a reference to a range of 90 to 100% includes 91%, 92%, 93%, 94%, 95%, 95%, 97%, etc., as well as 91.1%, 91.2%, 91.3%, 91.4%, 91.5%, etc., 92.1%, 92.2%, 92.3%, 92.4%, 92.5%, etc.
[0112] As used herein, "plant" encompasses any type of plant, specifically individual plants or plant varieties of agricultural, forestry, and ornamental plants.
[0113] As used herein, the term "pest" or "pests" or its grammatical equivalent is understood to refer to unwanted organisms that infest human structures, dwellings, living spaces, or food, as well as organisms including, for example, pathogens, that have a negative effect on a host or other organism, such as plants or animals, by mass habitation, damage, attack, competition for nutrients, infestation, or infection. Pests include, but are not limited to, fungi, weeds, nematodes, mites, and arthropods, including insects, arachnids, and cockroaches. The term "pest" or "pests" or its grammatical equivalent is understood to refer to organisms that have a negative effect by infesting materials such as plants and seeds, and stored grains.
[0114] As used herein, the terms “pesticide” or “of a pesticide” or their grammatical equivalents are understood to refer to any composition or substance that may be used for the control of any agricultural, natural environment, and household / household pests. The terms “control” or “controlling” are intended to include, but not be limited to, any killing, inhibiting, growth-regulating, or pestistactic activity of the composition against a given pest. These terms include, for example, sterilizing activity that prevents the production or normal development of seeds, eggs, sperm, or spores, causes the death of seeds, sperm, eggs, or spores, or otherwise causes serious damage to genetic material. Additional activities intended to be included within the scope of the term “control” or “controlling” include preventing larvae from developing into mature generations, preventing hatching, decomposing egg material, suffocating, controlling the emergence of pests from eggs including interference with mycelial growth, reducing gastrointestinal motility, inhibiting chitin formation, interfering with mating or sexual communication, blocking feeding activity (feeding repellents), and interfering with the location of hosts, mates, or nutrient sources. The term “pesticides” includes fungicides, herbicides, nematicides, insecticides, etc. The term “pesticides” includes, but is not limited to, naturally occurring compounds as well as so-called “synthetic chemical pesticides” having structures or formulations that do not occur naturally, and pesticides may be obtained by various means including, but not limited to, extraction from biological sources, chemical synthesis of compounds, and chemical modification of naturally occurring compounds obtained from biological sources.
[0115] As used herein, the terms “insecticidal,” “acnidarian,” or “aphidarian,” or their grammatical equivalents, are understood to refer to substances having pesticide activity against organisms included by the taxonomic classification of the root term, and substances having pesticide activity against organisms included by the common use of the root term, the common use of which may not strictly follow the taxonomic classification. The term “insecticidal” is generally understood to refer to substances having pesticide activity against organisms known as insects of the class Insecta of the phylum Arthropoda. Additionally, as provided herein, the term is also understood to refer to substances having pesticide activity against other organisms commonly referred to as “insects” or “worms” that may be classified into taxonomic classes different from Insecta but are included in the phylum Arthropoda. Based on this understanding, the term "insectogenic" may be used to refer to a substance having activity against arachnids (Arachnida), specifically mites (Acari / Acarina subclass). The term "acnidogenic" is understood to refer to a substance having pesticide activity against mites (acnid / mites) of the phylum Arthropoda, class Arachnida, and subclass Acari / Acarina. The term "aphidogenic" is understood to refer to a substance having pesticide activity against aphids (Aphididae) of the phylum Arthropoda, class Insecta, and family Aphididae. All of these terms are understood to be included in the terms "pesticide" or "pesticide" or their grammatical equivalents. These terms are not necessarily mutually exclusive, and it is understood that a substance known as an “insecticide” may have pesticidal activity against organisms of any family of the class Insecta, including aphids, and organisms included by other common uses of the terms “insect” or “worm,” including arachnids and mites. It is understood that an “insecticide” may also be known as an acaricide if it has pesticidal activity against mites, or as an aphidicide if it has pesticidal activity against aphids.
[0116] As used herein, the term "control" or "controlling" or its grammatical equivalent is understood to include any pesticide (killing) activity or pestistactic (inhibiting, repelling, inhibiting, and generally interfering with pest function to prevent damage to host plants) activity of a pesticide composition against a given pest. Accordingly, the term "control" or "controlling" or its grammatical equivalent includes not only killing but also activities such as repelling, inhibiting, inhibiting, or killing egg development or hatching, inhibiting maturation or development, and chemosterilization of larvae or adults. Repellent or inhibiting activity may be the result of compounds that are toxic to pests, have low toxicity, or are non-toxic, or may act as pheromones in the environment.
[0117] As used herein, the term “pesticide effective amount” generally refers to the amount of the mixture or composition containing the mixture required to achieve an observable effect on growth, including effects of necrosis, death, delay, prevention, and elimination, destruction, or other reduction in the occurrence and activity of target pest organisms. The pesticide effective amount may vary for the various mixtures / compositions used in the present invention. The pesticide effective amount of the mixture / composition will also vary depending on dominant conditions such as the desired pesticide effect and duration, weather, target species, location, method of application, etc.
[0118] As used herein, agriculturally suitable or acceptable salts, aquatic or mammal-suitable salts may be, for example, one or more of potassium, sodium, calcium, aluminum, other suitable metal salts of C6-C10 saturated or unsaturated aliphatic acids, ammonium, and other agriculturally acceptable salts.
[0119] As used herein, where a range of values is provided, it is understood that each intervening value between the upper and lower limits of the range, up to one-tenth of the unit of the lower limit unless the context clearly indicates otherwise, and any other mentioned value or intervening value within the mentioned range are included within the embodiments of the present invention. It should be understood that the upper and lower limits of these smaller ranges may independently define smaller ranges of values, and that these smaller ranges are intended to be included within the embodiments of the present invention, subject to any clearly excluded limit from the mentioned range.
[0120] In one embodiment according to the present disclosure, a synergistic pesticide composition comprises a C6-C10 saturated or unsaturated aliphatic acid (or an agriculturally acceptable salt thereof) and at least one pesticide active ingredient. As used herein, all references to C6-C10 saturated or unsaturated aliphatic acid include saturated or unsaturated aliphatic acids having 6 to 10 carbon atoms, e.g., C6, C7, C8, C9, or C10, any combination or subcombination thereof, e.g., C6 and C8, C7 and C10, C6, C9, and C10, etc. In some embodiments, the effective dose of the pesticide active ingredient when used in combination with one or more C6-C10 saturated or unsaturated aliphatic acids is lower than the effective dose of the pesticide active ingredient when used alone (i.e., when used as a synergistic composition with one or more C6-C10 saturated or unsaturated aliphatic acids, a smaller amount of the pesticide active ingredient can still control pests). In some embodiments, an active ingredient of a pesticide that is not effective against a specific species of pest may become effective against that specific species when used as a synergistic composition with one or more C6-C10 saturated or unsaturated aliphatic acids. In some of these embodiments, the pesticide composition may comprise a C11 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof. In some additional of these embodiments, the pesticide composition may comprise a C12 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof.
[0121] Without being bound by any specific theory, one or more C6-C10 saturated or unsaturated aliphatic acids according to some embodiments of the present disclosure act as cell permeability agents and, when combined with a suitable pesticide active ingredient, are believed to facilitate the entry of the pesticide active ingredient into the cell of a target pest or pathogen, preferably thereby providing synergistic activity of such synergistic pesticide composition. For example, all eukaryotic cell membranes, including fungal cell membranes and insect and nematode cell membranes, are biochemically similar in that they all contain a lipid bilayer composed of phospholipids, glycolipids, and sterols, as well as a significant number of proteins (Cooper & Hausmann 2013). The amphiphilic structure of the lipid bilayer and the polarity of membrane proteins restrict the passage of extracellular compounds across the membrane and enable compartmentalization of internal organelles from the intracellular environment. Without being bound by theory, one or more C6-C10 saturated or unsaturated aliphatic acids according to some embodiments disclosed herein are believed to act as cell permeation agents and, when combined with a suitable pesticide active ingredient, may act to enhance the entry of the active ingredient (same as but not limited to fungicidal, insecticidal, acaricidal, mollusk-killing, bactericidal, and nematode activities) into the cell of a target pest or pathogen (such as, but not limited to, fungi, insects, mites, mollusks, bacteria, and nematodes, respectively) and / or into intracellular organelles or intracellular bodies.In additional embodiments, without being bound by theory, the size and / or polarity of a number of pesticide molecules prevent and / or limit the crossing of the cell membrane of the pesticide active ingredient, but the addition of one or more C6-C10 saturated or unsaturated aliphatic acids according to some embodiments of the present disclosure is preferably believed to impair or disrupt the lipid bilayer integrity and protein organization of the pest cell membrane to create membrane gaps and / or increase membrane fluidity, thereby enabling, for example, the pesticide active to enter more effectively into the cells and / or intracellular organelles of the pest cell.
[0122] In another aspect, without being bound by any particular theory, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) according to some embodiments of the present disclosure are believed to act as at least one of reinforcing agents, synergists, adjuvants, and / or agents when combined with a suitable pesticide active ingredient, preferably providing synergistic activity of such synergistic pesticide composition against target pests or pathogens.
[0123] In some embodiments according to the present disclosure, the synergistic pesticide composition according to the present invention comprises, in combination with a pesticide, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) as exemplary cell permeators. In some embodiments, the synergistic composition comprises, in combination with a fungicide, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) as exemplary cell permeators. In some embodiments, the synergistic composition comprises, in combination with a nematicide, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) as exemplary cell permeators. In some embodiments, the synergistic composition comprises, in combination with an insecticide, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) as exemplary cell permeators.
[0124] In one such embodiment, without being bound by a specific theory, one or more C6-C10 saturated or unsaturated aliphatic acids are believed to act as cell membrane delivery agents to facilitate, for example, the passage of the pesticide active ingredient into the mitochondria of pest cells, thereby improving the entry and / or bioavailability or systemic distribution of the pesticide active ingredient into target pest cells and / or organelles within pest cells. In some other embodiments, without being bound by a specific theory, one or more C6-C10 saturated or unsaturated aliphatic acids may further provide synergistic interactions with one or more additional compounds provided as part of the pesticide composition, such as, for example, one or more additional C6-C10 saturated aliphatic acids, or one or more C6-C10 unsaturated aliphatic acids, or one or more additional active ingredients or adjuvants, thereby providing a synergistic enhancement of the pesticide effect provided by at least one pesticide active ingredient.
[0125] In another aspect, without being bound by any particular theory, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) according to some embodiments of the present disclosure are believed to act as at least one of reinforcing agents, synergists, adjuvants and / or agents when combined with suitable pesticide components, preferably providing synergistic activity of such synergistic pesticide compositions against target pests or pathogens.
[0126] Without being bound by any particular theory, in some embodiments of the present invention, one or more C6-C10 saturated or unsaturated aliphatic acids are believed to act to impair or alter the integrity of the lipid bilayer and protein organization of the cell membrane in target pest organisms. Additionally, in some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids are particularly suitable for combinations forming a synergistic pesticide composition according to embodiments of the present invention, which demonstrate synergistic efficacy with a pesticide active agent having a mode of action that depends on interactions with one or more components of the target pest cell membrane. In some such embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids may be particularly suitable for combinations forming a synergistic pesticide composition, which demonstrate synergistic efficacy with a pesticide active agent having a mode of action that depends on interactions with cell membrane proteins. In one such embodiment, the cell membrane protein may include one or more cytochrome complexes, such as, for example, the cytochrome bc1 complex or the cytochrome p450 complex. Accordingly, in one embodiment, a synergistic pesticide composition according to some embodiment of the present invention may preferably be selected to comprise one or more C6-C10 saturated or unsaturated aliphatic acids and one or more pesticide active ingredients having a mode of action that depends on interaction with one or more components of a target pest cell membrane, e.g., a cell membrane protein. In one embodiment, one or more C11 or C12 saturated or unsaturated aliphatic acids are provided in combination with one or more pesticide active ingredients having a mode of action that depends on interaction with one or more components of a target pest cell membrane, e.g., a cell membrane protein.
[0127] In a specific embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids are particularly suitable for combination to form a synergistic pesticide composition according to an embodiment of the present invention, which includes, for example, azoxystrobin, cumoxastrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, cresoxim-methyl trifloxystrobin, dimoxastrobin, phenaminestrobin, metominostrobin, orysastrobin, fungicide actives collectively referred to as Group 11 actives by the Fungicide Resistance Action Committee (FRAC), such as a cell membrane cytochrome bc1 complex (also known as cytochrome complex III) and (e.g., one or more receptor sites Demonstrates synergistic efficacy with a pesticide active having an interacting mode of action (by inhibiting). In one such embodiment, the synergistic pesticide composition may be selected to include one or more C6-C10 saturated or unsaturated aliphatic acids, and a pesticide active having a mode of action that interacts with the cellular cytochrome bc1 complex, such as a strobilurin pesticide active. In an alternative such embodiment, the synergistic pesticide composition includes one or more C11 or C12 saturated or unsaturated aliphatic acids.
[0128] In another specific embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids are particularly suitable for combination to form a synergistic pesticide composition according to an embodiment of the present invention, which are, for example, triporin, pyrifenox, pyrixoxazole, fenarimol, nuarimol, imazalyl, oxpoconazole, pefurazoeate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxyconazole, ethaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, microbutanil, fenconazole, propiconazole, simeconazole, tebuconazole, tetraconazole, triadimephon, Demonstrates synergistic efficacy with an agronomic active having a mode of action that interacts with the cell membrane cytochrome p450 complex (e.g., by inhibiting one or more receptor sites), such as in the case of exemplary fungicide actives collectively referred to as FRAC group 3 actives, including triadimenol, triticonazole, or prothioconazole. In one such embodiment, the synergistic agronomic composition may be selected to comprise one or more C6-C10 saturated or unsaturated aliphatic acids and an agronomic active having a mode of action that interacts with the cell cytochrome p450 complex, such as, for example, an azole or triazole agronomic active. In an alternative such embodiment, the synergistic agronomic composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.
[0129] In another specific embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids are particularly suitable for combination to form a synergistic pesticide composition according to an embodiment of the present invention, which demonstrates synergistic efficacy with a pesticide active having a mode of action that interacts with a cell membrane (e.g., by inhibiting one or more receptor sites), such as uncoupling oxidative phosphorylation, as in the case of exemplary pesticide actives collectively referred to as Group 13 actives by the Insecticide Resistance Action Committee (IRAC), such as quinoxifene or proquinazide. In one such embodiment, the synergistic pesticide composition may be selected to include one or more C6-C10 saturated or unsaturated aliphatic acids and a pesticide active having a mode of action that interacts with a cell membrane, such as chlorfenapyr, a pyrrole pesticide active. In this alternative embodiment, the synergistic pesticide composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.
[0130] Without being bound by any particular theory, in some additional embodiments of the present invention, one or more C6-C10 saturated or unsaturated aliphatic acids act to impair or alter the integrity of the lipid bilayer and protein organization of the cell membrane of a target pest organism, thereby being effective in increasing at least one of the fluidity and permeability of the cell membrane of the target pest organism, which is preferably believed to increase, for example, the permeability and / or delivery of the pesticide active agent through the cell membrane. Additionally, in some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids are particularly suitable for combinations to form a synergistic pesticide composition according to an embodiment of the present invention, which demonstrates synergistic efficacy with a pesticide active agent having a mode of action that relies on delivery across one or more cell membranes of the target pest, such as interacting with target sites within the cells or intracellular organelles of the target pest. In some of these embodiments, a synergistic pesticide composition according to an embodiment of the present invention demonstrating synergistic efficacy may comprise one or more C6-C10 saturated or unsaturated aliphatic acids and one or more pesticide actives having a mode of action that depends on delivery across a cell membrane. Accordingly, in one embodiment, a synergistic pesticide composition according to some embodiment of the present invention may preferably be selected to comprise one or more C6-C10 saturated or unsaturated aliphatic acids and one or more pesticide actives having a mode of action that depends on interaction with a target site within a cell or intracellular organelle of a target pest, such as a cell membrane protein. In an alternative embodiment, the synergistic pesticide composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.
[0131] In a specific embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids are particularly suitable for combination to form a synergistic pesticide composition according to an embodiment of the present invention, which demonstrates synergistic efficacy with a pesticide active having a mode of action that interacts at a target site across the cell membrane of a target pest (e.g., by inhibiting one or more receptors), such as fungicide actives collectively referred to as FRAC group 9 and group 12 actives, including, for example, cyprodinyl, mepanipyrim, pyrimethanil, fenpiclonil, or fludioxonil. In one such embodiment, the synergistic pesticide composition may be selected to include one or more C6-C10 saturated or unsaturated aliphatic acids, and a pesticide active having a mode of action that interacts at a target site within the cell membrane of a target pest, such as, for example, anilinopyrimidine such as cyprodinyl, and phenylpyrrole such as fludioxonil. In this alternative embodiment, the synergistic pesticide composition comprises one or more C11 or C12 saturated or unsaturated aliphatic acids.
[0132] Without being bound by any particular theory, in some additional embodiments of the present invention, one or more C6-C10 saturated or unsaturated aliphatic acids act to impair or alter the integrity of the lipid bilayer and protein organization of the cell membrane in a target pest organism, thereby being effective in increasing at least one of the fluidity and permeability of the cell membrane of the target pest organism, which is preferably believed to increase, for example, the permeability and / or delivery of the pesticide active ingredient through the cell membrane. Additionally, in some preferred embodiments, one or more C6-C10 unsaturated aliphatic acids having unsaturated CC bonds at one or more of the second (2-), third (3-), and terminal ((n-1)-) positions of the aliphatic acid carbon chain are particularly suitable for combinations to form a synergistic pesticide composition according to an embodiment of the present invention, which is also believed to demonstrate synergistic efficacy with the pesticide active ingredient. In some specific embodiments, one or more C6-C10 aliphatic acids containing unsaturated CC bonds at one or more of the 2-, 3- and (n-1)- positions (where n is the number of carbons of the unsaturated aliphatic acid) may be particularly suitable for forming a synergistic pesticide composition in combination with one or more pesticide active ingredients having a mode of action that preferably relies on interaction with a cell membrane component of a target pest or relies on delivery across one or more cell membranes of a target pest (such as interacting with a target site within a cell or intracellular organelle of a target pest). In some of these embodiments, a synergistic pesticide composition according to an embodiment of the present invention demonstrating synergistic efficacy may comprise one or more C6-C10 unsaturated aliphatic acids having unsaturated CC bonds at one or more of the 2-, 3- and terminal ((n-1)-) positions of the aliphatic acid carbon chain, and one or more pesticide active ingredients having a mode of action that depends on interaction with a target pest cell membrane component or delivery across the target pest cell membrane.In this alternative embodiment, the synergistic pesticide composition comprises one or more C11 or C12 unsaturated aliphatic acids having unsaturated CC bonds at one or more of the 2-, 3- and terminal ((n-1)-) groups.
[0133] In some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) comprise an aliphatic carbonyl alkene. In some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) comprise at least one C6-C10 unsaturated aliphatic acid having at least one carboxylic acid group and at least one unsaturated CC bond. In another embodiment, the C6-C10 unsaturated aliphatic acid (or agriculturally acceptable salts thereof) comprises at least two C6-C10 unsaturated aliphatic acids having at least one carboxylic acid group and at least one unsaturated CC bond. Also, in yet another embodiment, the C6-C10 unsaturated aliphatic acid (or agriculturally acceptable salts thereof) comprises at least one carboxylic acid group and at least one of a double or triple CC bond. In a further embodiment, a synergistic pesticide composition is provided comprising at least one C6-C10 unsaturated aliphatic acid (or an agriculturally acceptable salt thereof) having at least one carboxylic acid group and at least one unsaturated CC bond by combining at least one pesticide active ingredient and at least one C6-C10 saturated aliphatic acid (or an agriculturally acceptable salt thereof). Also, in another embodiment, the C6-C10 saturated or unsaturated aliphatic acid may be provided, for example, as a plant extract or oil containing at least one C6-C10 saturated or unsaturated aliphatic acid, or as a fraction thereof.
[0134] In some embodiments, one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) are of the general structure shown in FIG. 1. (1) ,(2) , (3) , (4) , (5) , (6) or (7) It includes an aliphatic carbonyl alkene having one of the following. In some embodiments, a C6-C10 saturated or unsaturated aliphatic acid may include an agriculturally acceptable salt form thereof.
[0135] In some embodiments, the composition comprises one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) and a fungicide active ingredient. In some embodiments, when used in combination with one or more C6-C10 saturated or unsaturated aliphatic acids, the effective dose of the fungicide active ingredient is lower than the effective dose of the fungicide active ingredient when used alone (i.e., when used in a composition with one or more C6-C10 saturated or unsaturated aliphatic acids, a smaller amount of fungicide active ingredient can still control fungi). In some embodiments, a fungicide active ingredient that is not effective against a specific species of fungus (e.g., at a specific concentration below the lower limit of efficacy against a specific species of fungus that may be at least partially resistant or tolerant to a specific fungicide active ingredient when applied alone) may become effective against that specific species when used in a composition with one or more C6-C10 saturated or unsaturated aliphatic acids.
[0136] In some embodiments, the composition comprises one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) and a nematicidal active ingredient. In some embodiments, when used in combination with one or more C6-C10 saturated or unsaturated aliphatic acids, the effective dose of the nematicidal active ingredient is lower than the effective dose of the nematicidal active ingredient when used alone (i.e., when used in a composition with one or more C6-C10 saturated or unsaturated aliphatic acids, a smaller amount of nematicidal active ingredient can still control nematodes). In some embodiments, a nematicide active ingredient that is not effective against a specific species of nematode (e.g., at a specific concentration below the lower limit of efficacy against a specific species of nematode, which may be at least partially resistant or tolerant to a specific nematicide active ingredient when applied alone) may become effective against that specific species when used in a composition together with one or more C6-C10 saturated or unsaturated aliphatic acids.
[0137] In some embodiments, the composition comprises one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) and an insecticidal active ingredient. In some embodiments, the effective dose of the insecticidal active ingredient when used in combination with one or more C6-C10 saturated or unsaturated aliphatic acids is lower than the effective dose of the insecticidal active ingredient when used alone (i.e., when used in the composition with one or more C6-C10 saturated or unsaturated aliphatic acids, a smaller amount of the insecticidal active ingredient can still control insects). In some embodiments, an insecticidal active ingredient that is ineffective against a specific species of insect (e.g., at a specific concentration below the lower limit of efficacy against a specific insect that may be at least partially resistant or tolerant to the specific insecticidal active ingredient when applied alone) may become effective against that specific species when used in the composition with one or more C6-C10 saturated or unsaturated aliphatic acids. In a further embodiment, one or more C6-C10 saturated or unsaturated aliphatic acids preferably provide a synergistic increased efficacy of at least one of the active ingredients of an acaricide, molluskicide, bactericidal or viralicide, so that the composition may have an agrochemical effect against one or more of, for example, mites, mollusks, bacteria, or viral pests.
[0138] In some embodiments, the composition comprises one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof) and a pesticide-resistant natural or essential oil, e.g., neem oil. In some embodiments, the pesticide-resistant natural oil may comprise, e.g., neem oil, caranza oil, clove oil, peppermint oil, mint oil, cinnamon oil, thyme oil, oregano oil, geranium oil, lime oil, lavender oil, anise oil, and / or garlic oil and / or one or more components, derivatives and / or extracts of one or more pesticide-resistant natural oils, or combinations thereof. In some embodiments, the pesticide-resistant natural oil is neem oil or a component or derivative thereof. In another embodiment, the pesticide-resistant natural oil comprises caranza oil or a component or derivative thereof. In yet another embodiment, the pesticide-resistant natural oil comprises thyme oil or a component or derivative thereof.
[0139] In another embodiment, the pesticide natural oil comprises, but is not limited to, thymol (found in oregano oil and thyme oil), p-cymene (found in oregano oil and thyme oil), 1,8-cineole (found in thyme oil and peppermint oil), eugenol (found in clove oil and cinnamon oil), limonene (found in cinnamon, peppermint, and lime oils), alpha-pinene (found in cinnamon oil, geranium oil, and lime oil), carvacrol (found in oregano oil, thyme oil, and clove oil), gamma-terpinene (found in oregano oil and lime oil), geraniol (found in thyme oil and geranium oil), alpha-terpineol (found in thyme oil and anise oil), beta-caryophyllene (found in clove oil, cinnamon oil, and peppermint oil), and linalool (found in thyme oil, cinnamon oil, and geranium oil, among others). It may include any natural oil or oil mixture containing one or more components common to two or more of the above-listed pesticide-resistant natural oils (i.e., neem oil, caranza oil, clove oil, peppermint oil, cinnamon oil, thyme oil, oregano oil, garlic oil, anise oil, geranium oil, lime oil, lavender oil).In another embodiment, the pesticide natural oil may comprise any oil having one of the following compounds or a combination of the following compounds as a component: azadirachtin, nimbin, nimbinin, salanin, gedunin, geraniol, geranial, gamma-terpinene, alpha-terpineol, beta-caryophyllene, terpinene-4-ol, myersenol-8, tuianol-4, benzyl alcohol, cinnamaldehyde, cinnamyl acetate, alpha-pinene, geranyl acetate, citronellol, citronellol formate, isomentone, 10-epi-gamma-eudesmol, 1,5-dimethyl-1-vinyl-4-hexenylbutyrate, 1,3,7-octatriene, eucalyptol, camphor, diallyl disulfide, methylallyl trisulfide, 3-vinyl-4H-1,2-dithyne, 3-vinyl-1,2-dithiol-5-cyclohexane, diallyl trisulfide, anethole, methyl chavicol, anisaldehyde, estragol, linalyl acetate, geranial, beta-pinene, thymol, carvacrol, p-cymene, beta-myrcene, alpha-myrcene, 1,8-cineole, eugenol, limonene, alpha-pinene, menthol, menthone, and linalool.
[0140] In further embodiments, the agrochemical natural oil may, without limitation, comprise one or more suitable plant essential oils or extracts or fractions thereof disclosed herein, including: alpha- or beta-pinene; alpha-campolene aldehyde; alpha.-citronellol; alpha-iso-amyl-cinnamic (e.g., amyl cinnamic aldehyde); alpha-pinene oxide; alpha-cinnamic terpinene; alpha-terpineol (e.g., 1-methyl-4-isopropyl-1-cyclohexene-8-ol); lambda-terpinene; achillea; aldehyde C16 (pure substance); allicin; alpha-phelandrene; amyl cinnamaldehyde; amyl salicylate; anethole; anise; anise seed; anisic aldehyde; basil; laurel; benzyl acetate; benzyl alcohol; Bergamot (e.g., Monardia fistulosa, Monarda didyma, Citrus bergamia, Monarda punctate); bitter orange peel; black pepper; borneol; calamus; camphor; cananga oil (e.g., Java); cardamom; Carnation (e.g., Dianthus caryophyllus); Carvacrol; Caveol; Cassia; Castor oil plant; Cedar (e.g., Hinoki); Cedarwood; Chamomile; Cineole; Cinnamaldehyde; Cinnamic alcohol; Cinnamon; Cis-Phinan; Citral (e.g., 3,7-Dimethyl-2,6-Octadienal); Citronella; Citronellal; Citronellol Dextro (e.g., 3-7-Dimethyl-6-Octen-1-ol); Citronellol; Citronellol Acetate; Citronellol Nitrile; Satsuma mandarin; Clary sage; Clove (e.g., Eugenia caryophyllus); Clove buds; Coriander; Corn; Cottonseed; d-Dihydrocarbon; Decylaldehyde; Diallyl disulfide; Diethyl phthalate; Dihydroanethol; dihydrocarbeol; dihydrolinalool; dihydromyrsene; dihydromyrsenol; dihydromyrsenyl acetate;Dihydroterpineol; dimethyl salicylate; dimethyl octanal; dimethyl octanol; dimethyl octanyl acetate; diphenyl oxide; dipropylene glycol; d-limonene; d-pulegone; estragol; ethyl vanillin (e.g., 3-ethoxy-4-hydrobenzaldehyde); eucalyptol (e.g., cineol); Eucalyptus citriodora; Eucalyptus globulus; eucalyptus; eugenol (e.g., 2-methoxy-4-allyl phenol); evening primrose; phencol; fennel; perniol™; fish; florazone (e.g., 4-ethyl-.alpha., .alpha.-dimethyl-benzenepropanal); galaxolide; geraniol (e.g., 2-trans-3,7-dimethyl-2,6-octadiene-8-ol); Geraniol; Geranium; Geranyl acetate; Geranyl nitrile; Ginger; Grapefruit; Guiacol; Guiaquewood; Gourjune balsam; Heliotropin; Herbanate (e.g., 3-(1-methyl-ethyl)bicyclo(2,2,1)hept-5-en-2-carboxylic acid ethyl ester); Hiba; Hydroxycitronellal; i-Carvone; i-methyl acetate; Ionone; Isobutyl quinolein (e.g., 6-2-butyl quinoline); Isobornyl acetate; Isobornyl methyl ether; Isoeugenol; Isorongipollen; Jasmine; Jojoba; Juniper berry; Lavender; Lavandin; Lemongrass; Lemon; Lime; Limonene; Linalool oxide; Linalool; Linalyl acetate; Flaxseed; Litsea cubeba; 1-methyl acetate; Longipollen; Mandarin; Mentha; Menthane hydroperoxide; Menthol crystals; Menthol laevo (e.g., 5-methyl-2-isopropylcyclohexanol); Menthol; Menthone laevo (e.g., 4-isopropyl-1-methylcyclohexan-3-one); Methyl anthranilate; Methyl cedryl ketone; Methyl chavicol; Methylhexyl ether; Methyl ionone; Mineral; Mint; Musk ambrette; Musk ketone; Musk xylorl; Mustard (also known as allyl isothiocyanate); Myrcene; Nerol; Neryl acetate; Nonylaldehyde;Nutmeg (e.g., Myristica fragrans); orange (e.g., Citrus aurantium dulcis); orris (e.g., Iris florentina) root; para-cymene; para-hydroxyphenylbutanone crystals (e.g., 4-(4-hydroxyphenyl)-2-butanone); passion palmarosa oil (e.g., cymbopogon martini); plantain (e.g., pogostemon cablin); p-cymene; pennyroyal oil; black pepper; peppermint (e.g., Mentha piperita); perillaldehyde; petitgrain (e.g., Citrus aurantium amara); phenyl ethyl alcohol; Phenyl ethyl propionate; phenyl ethyl-2-methylbutyrate; pimento berry; pimento leaf; pinan hydroperoxide; pinanol; pine ester; pine leaf; pine; pinene; piperonal; piperonyl acetate; piperonyl alcohol; plinol; plinyl acetate; pseudo-ionone; rhodinol; rhodinyl acetate; rosalin; rose; rosemary (e.g., Rosmarinus officinalis); genus; sage; sandalwood (e.g., Santalum album); sandenol; sassafras; sesame; soybean; spearmint; spice; spike lavender; spranthol; starflower; tangerine; tea seed; tea tree; terpenoid; terpineol; terpinolene; terpinyl acetate; tert-butylcyclohexyl acetate; tetrahydrolinalool; tetrahydrolinalyl acetate; tetrahydromyrsenol; Tulashi; thyme; thymol; tomato; trans-2-hexenol; trans-anethol and its metabolites; turmeric; tourpentine; vanillin (e.g., 4-hydroxy-3-methoxybenzaldehyde); vetiver; vitalizaire; white cedar; white grapefruit;Wintergreen (methyl salicylate) oil, etc.;
[0141] In some embodiments, when used in combination with one or more C6-C10 saturated or unsaturated aliphatic acids (or agriculturally acceptable salts thereof), the effective dose of the pesticide natural oil is lower than the effective dose of the pesticide natural oil when used alone (i.e., when used in a composition with one or more C6-C10 saturated or unsaturated aliphatic acids, a smaller amount of the pesticide natural oil can still control pests). In some embodiments, an essential oil that is not effective against a specific species of pest may become effective against that specific species when used in a composition with one or more C6-C10 saturated or unsaturated aliphatic acids.
[0142] In some embodiments, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise a naturally occurring aliphatic acid, such as one that may be present in, extracted from, fractionated from, or derived from, for example, natural plant or animal material. In one such embodiment, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in a plant extract or a fraction thereof. In another such embodiment, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise one or more naturally occurring aliphatic acids provided in an animal extract or product, or a fraction thereof. In one such embodiment, at least one C6-C10 saturated or unsaturated alpha-acid may comprise a naturally occurring aliphatic acid contained in a plant oil extract, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts derived therefrom. In another such embodiment, at least one C6-C10 saturated or unsaturated aliphatic acid may comprise a naturally occurring aliphatic acid contained in an animal extract or product, such as, for example, one or more of cow's milk, goat's milk, tallow, and / or cow or goat butter, or fractions or extracts thereof. In a specific embodiment, at least one C6-C10 saturated or unsaturated aliphatic acid may be provided as a component of one or more natural plant or animal materials, or extracts or fractions thereof. In a specific such embodiment, at least one C6-C10 saturated aliphatic acid may be provided in an extract or fraction of one or more plant oil extracts, such as one or more of coconut oil, palm oil, palm kernel oil, corn oil, or fractions or extracts derived therefrom.
[0143] In some embodiments, an emulsifier or other surfactant may be used to prepare a pesticide composition according to an aspect of the present disclosure. A suitable surfactant may be selected by a person skilled in the art. Examples of surfactants that may be used in some embodiments of the present disclosure include, but are not limited to, sodium lauryl sulfate, saponin, ethoxylated alcohol, ethoxylated fatty ester, alkoxylated glycol, ethoxylated fatty acid, ethoxylated castor oil, glyceryl oleate, carboxylated alcohol, carboxylic acid, ethoxylated alkylphenol, fatty ester, sodium dodecyl sulfide, other natural or synthetic surfactants, and combinations thereof. In some embodiments, the surfactant(s) are non-ionic surfactants. In some embodiments, the surfactant(s) are cationic or anionic surfactants. In some embodiments, the surfactant may comprise two or more surfactants used in combination. The selection of a suitable surfactant depends on the relevant application and usage conditions, and the selection of a suitable surfactant is known to those skilled in the art.
[0144] In one embodiment, a pesticide composition according to some embodiments of the present disclosure comprises one or more suitable carrier or diluent components. The suitable carrier or diluent component may be selected by a person skilled in the art depending on the desired specific application and use conditions of the composition. Commonly used carriers and diluents include, for example, citric acid, lactic acid, glycerol, castor oil, benzoic acid, carbonic acid, ethoxylated alcohol, ethoxylated amide, glyceride, benzene, butanol, 1-propanol, hexanol, other alcohols, dimethyl ether, and polyethylene glycol, each of which is incorporated herein in its entirety for all purposes by the EPA as a least risk inactive pesticide component (4A) (a list of components published in December 2015 under the US EPA FIFRA 4a list published in August 2004 under the title "List 4A - Less Risk Inactive Components"), or, for example, as an inactive pesticide component (4B) (a list of components published in August 2004 under the title "List 4B - Other Components for which the EPA has sufficient information") by the EPA or in May 2002 It may include ethanol, isopropanol, isopropyl myristate, other alcohols, water, and other inert carriers, which are the same as but not limited to those listed under EPA Regulation 40CFR 180.950 of the 24th.
[0145] In one embodiment according to the present disclosure, a method for improving the efficacy of a pesticide is provided. In one embodiment, a method for improving the efficacy of a fungicide is provided. In another embodiment, a method for improving the efficacy of a nematicide is provided. In an additional embodiment, a method for improving the efficacy of an insecticide is provided.
[0146] In one such embodiment, the method comprises providing a synergistic pesticide composition comprising a pesticide active ingredient and at least one C6-C10 saturated or unsaturated aliphatic acid and exposing pests to the resulting synergistic composition. In specific exemplary embodiments, without being bound by any particular theory, at least one C6-C10 saturated or unsaturated aliphatic acid may preferably function as a cell permeability agent or a cell membrane disruptor. In one embodiment, the method comprises providing a fungicide composition comprising a fungicide active ingredient and at least one C6-C10 saturated or unsaturated aliphatic acid and exposing fungi to the resulting synergistic composition. In another embodiment, the method comprises providing a nematicide composition comprising a nematicide active ingredient and at least one C6-C10 saturated or unsaturated aliphatic acid and exposing nematodes to the resulting synergistic composition. In a further embodiment, the method comprises providing an insecticide composition comprising an insecticide active ingredient and at least one C6-C10 saturated or unsaturated aliphatic acid, and exposing an insect to the resulting synergistic composition.
[0147] In one embodiment according to the present disclosure, at least one C6-C10 saturated or unsaturated aliphatic acid provided in the pesticide composition comprises an unsaturated aliphatic carbonyl alkene. In a specific such embodiment, without being bound by any particular theory, at least one C6-C10 saturated or unsaturated aliphatic acid may preferably function as a cell permeability agent or a cell membrane disturbance agent. In one such embodiment, the cell permeability agent is a general structure shown in FIG. 1. (1) , (2) , (3) , (4) , (5) , (6) or (7)It includes a carbonyl alkene having. In a further embodiment, the cell permeation agent includes at least one unsaturated aliphatic acid having at least one carboxyl group and at least one unsaturated CC bond.
[0148] In one exemplary embodiment, the method comprises providing a synergistic pesticide composition comprising a pesticide active ingredient and at least one C6-C10 saturated or unsaturated aliphatic acid functioning as a cell permeator, and exposing a pest to the synergistic pesticide composition to increase the amount of the pesticide active ingredient entering the pest's cell. In some of these embodiments, the pesticide active ingredient is a fungicide and the pest is a fungus, and without being bound by any specific theory, the at least one C6-C10 saturated or unsaturated aliphatic acid cell permeator enables the fungicide to pass more easily through the fungal cell wall and membrane. In some of these embodiments, the pesticide is a nematicide and the pest is a nematode, and without being bound by any specific theory, the at least one C6-C10 saturated or unsaturated aliphatic acid cell permeator enables the nematicide to pass more easily through the nematode cell membrane. In some of these embodiments, the pesticide is an insecticide, and without being bound by any specific theory, at least one C6-C10 saturated or unsaturated aliphatic acid cell permeable agent enables the insecticide to pass more easily through the insect fungus cuticle, chitin membrane, or cell or intracellular membrane.
[0149] In some embodiments, in addition to the actual synergy with respect to pesticide activity, certain synergistic pesticide compositions according to embodiments of the present disclosure may also preferably have more remarkable advantageous properties. Examples of such additional advantageous properties may include one or more of: more favorable degradability in the environment; and improvements in toxicological and / or environmental toxicological behavior, such as, for example, reduced aquatic toxicity or toxicity to beneficial insects.
[0150] In any of the embodiments described above or below, which provide a synergistic pesticide composition comprising at least one pesticide active ingredient and one or more C6-C10 saturated or unsaturated aliphatic acids or salts thereof, in an alternative embodiment, the synergistic pesticide composition may alternatively comprise at least one pesticide active ingredient and one or more C11 saturated or unsaturated aliphatic acids or salts thereof. In another embodiment, regarding any of the embodiments described above, which provide a synergistic pesticide composition comprising at least one pesticide active ingredient and one or more C6-C10 saturated or unsaturated aliphatic acids or salts thereof, in an alternative embodiment, the synergistic pesticide composition may alternatively comprise at least one pesticide active ingredient and one or more C12 saturated or unsaturated aliphatic acids or salts thereof.
[0151] Experimental method
[0152] According to an embodiment of the present disclosure, a combination of at least one C6-C10 saturated or unsaturated aliphatic acid and a pesticide active ingredient produces a synergistic pesticide composition exhibiting a synergistic pesticide effect. In some embodiments, the synergy between the pesticide active ingredient and at least one C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid component of the pesticide composition according to an embodiment of the present disclosure was tested using a synergistic growth inhibition assay, which is derived from and related to the checkerboard assay known in the art for testing combinations of antimicrobial agents. In the synergistic growth inhibition assay used according to some embodiments of the present disclosure, multiple dilutions of the combination of the pesticide active ingredient and at least one C6-C10 saturated or unsaturated aliphatic acid formulation are tested in individual cells for inhibitory activity against target pests or pathogen organisms. In one such embodiment, a combination of the pesticide active ingredient and a C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulation may preferably be tested at decreasing concentrations. In a further such embodiment, a combination of the pesticide active ingredient and a C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulation may be tested at increasing concentrations. These multiple combinations of the pesticide active ingredient and at least one C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulation may be prepared in a 96-well microtiter plate. In one such embodiment, a synergistic growth inhibition assay then tests for the MIC of the formulation of the combination that inhibits the growth of the target pest or pathogen, including rows containing sequentially decreasing concentrations of the pesticide active ingredient and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations.Therefore, each well of the microtiter plate is a unique combination of two agents, where the inhibitory efficacy of the combination against target pests or pathogens can be determined.
[0153] A method for determining and quantifying synergistic efficacy is based on the calculation of the “fractional inhibitory concentration index” or FIC index known in the art to determine synergy between two antibiotics (e.g., reference to the literature [MJ Hall et al., “The fractional inhibitory concentration (FIC) index as a measure of synergy”, J Antimicrob Chem., 11 (5):427-433, 1983], e.g.). In one embodiment according to the present disclosure, for each row of microtiter cells in a synergistic growth inhibition assay, the FIC index is calculated from the minimum concentration of one or more C6-C10 saturated or unsaturated aliphatic acid preparations and the pesticide active ingredient required to inhibit the growth of a target pest or pathogen. The FIC of each component is derived by dividing the concentration of the preparation present in the wells of the microtiter plate by the minimum inhibitory concentration (MIC) required for that preparation alone to inhibit the growth of the target pest or pathogen. Subsequently, the FIC index is the sum of these values for both formulations in the wells of the microtiter plate. The FIC index is calculated for each row as follows:
[0154] FIC 지수 = MIC a / MIC A + MIC b / MIC B
[0155] MIC here a , MIC b is the minimum inhibitory concentration (MIC) of compounds A and B, respectively, when combined as a mixture of the compositions, and MIC A , MIC B≡ 지수 < 1), a combination of a pesticide active ingredient and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations exhibits synergy and suggests a synergistic pesticide composition. If the FIC index is 1, the combination is additive. An FIC index value greater than 4 is considered to exhibit antagonistic activity.
[0156] In a specific embodiment, when the FIC index is 0.5 or less, the combination of the pesticide active ingredient and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations exhibits a strong synergistic effect. For example, in one embodiment, an FIC index of 0.5 may correspond to a synergistic pesticide composition comprising a pesticide formulation at ¼ of its individual MIC and one or more (or alternatively C11 or C12) C6-C10 saturated or unsaturated aliphatic acid formulations at ¼ of its individual MIC.
[0157] In some embodiments of the present disclosure, an exemplary synergistic growth inhibition analysis was performed starting with an initial composition comprising a pesticide active ingredient formulation (Compound A) at its individual MIC and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations (Compound B) at their individual MIC in the first well of a row on a 96-well microtiter plate. Subsequently, using sequential dilutions of these initial compositions in successive wells within the row of the microtiter plate, the pesticide composition was analyzed under the same conditions to determine the concentration of the composition combining the two formulations corresponding to the microtiter well where growth inhibition of the target pest or organism ceased. The minimum inhibitory concentration of each individual pesticide active ingredient formulation (Compound A) and one or more C6-C10 saturated or unsaturated aliphatic acid formulations (as Compound B) was determined in parallel with the composition combining the two formulations.
[0158] In some embodiments, to determine synergy in a pesticide composition comprising a pesticide active ingredient formulation (Compound A) and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations (Compound B). Fusarium oxysporum ( Fusarium oxysporum ) was used as a representative pest organism or pathogen. In the wells of the 96-well microtiter plate used in the exemplary synergistic growth inhibition analysis Fusarium oxysporum Resazurin dye (also known as Alamar blue dye) was used as an indicator to determine the presence or inhibition of growth. Fusarium oxysporum In addition to the color change of the resazurin dye in the presence of growth, optical or visual inspection of the microtiter wells may also be performed to further determine the presence or inhibition of growth of Fusarium oxysporum.
[0159] In another embodiment, to determine synergy in a pesticide composition comprising a pesticide active ingredient (compound A) and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid preparations (compound B). Botrytis Cinerea ( Botrytis cinerea ) was used as a representative pest organism or pathogen. Similarly to what is described above, in an exemplary synergistic growth inhibition analysis Botrytis Cinerea Resazurin was used as an indicator of growth or growth inhibition. In addition to the color change of resazurin, optical or visual inspection of microtiter wells was also Botrytis Cinerea It may be done to further determine the presence of growth or growth inhibition.
[0160] In a further embodiment, to determine synergy in a pesticide composition comprising a pesticide active ingredient (compound A) and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid preparations (compound B). Slerotinia slerothiorum ( Sclerotinia sclerotiorum ) was used as a representative pest organism or pathogen. Similarly to what is described above, in an exemplary synergistic growth inhibition analysis Slerotinia slerothiorum Resazurin was used as an indicator of growth or growth inhibition. In addition to the color change of resazurin, optical or visual inspection of microtiter wells was also Slerotinia slerothiorum It may be done to further determine the presence of growth or growth inhibition.
[0161] Alternatively, other suitable representative pests or pathogens may be used to determine the synergy of a combination of a pesticide active ingredient formulation and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations according to an embodiment of the present disclosure. For example, Leptosphaeria Maculans ( Leptosphaeria maculans ), Slerotinia species and Verticillium species ( Verticillium sppOther representative fungal pathogens, such as but not limited to .) may be used. In addition, in other embodiments, suitable representative non-fungal pests or pathogens may be used, such as insects, mites, nematodes, bacteria, viruses, mollusks, or other pests or pathogens suitable for use in the MIC growth inhibition analysis test method.
[0162] All examples described below were tested according to the exemplary synergistic growth inhibition analysis described above, using routine techniques for determining MIC known to those skilled in the art. Stock solutions of the pesticide active ingredient formulation and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid formulations were initially prepared in 100% dimethyl sulfoxide ("DMSO") and diluted to 10% DMSO using sterile potato dextrose broth (PDB) prior to further sequential dilution to obtain test solution concentrations for use in microtiter plate wells, with the exception of specific experimental examples described in detail below. Accordingly, the maximum concentration of DMSO in the test solution was limited to 10% DMSO or less, which was separately determined to be non-inhibitory against the growth of the representative fungal pests used in the test.
[0163] Representative fungal pathogens, that is, for example, Fusarium oxysporum , Botrytis cinerea, or Slerotinia slerothiorumThe culture is grown in potato dextrose broth (PDB) until the exponential growth phase. A 20 μL aliquot of homogenized mycelium from the culture is transferred to a well of a 96-well microtiter plate and incubated for a period of 1 to 7 days (depending on the pathogen and specific analytical reagents mentioned in the description of the examples below) using 180 μL of a test solution containing a combination of pesticides and aliphatic acid preparations in various dilution ranges to allow the mycelium to grow. After the incubation period, 10 μL of resazurin dye is added to each well, and the color of the solution is observed and compared with the color of the test solution at the same concentration in wells without the mycelial culture inoculum as a control for the effect of the test solution alone. The resazurin dye appears blue for wells containing only the initial 20 µL culture in which growth is inhibited, and pink for wells where mycelial growth has occurred, as shown in Fig. 2, where the transition from blue to pink can be clearly seen in each of the top four rows of microtiter wells (labeled 1 to 4 in Fig. 2) as the concentration of the pesticide and one or more C6-C10 (or alternatively C11 or C12) saturated or unsaturated aliphatic acid preparations in the test solution decreases from left to right. In addition to the color change of the resazurin dye, the growth or absence of growth of the mycelial culture is also observed visually or optically.
[0164] According to this analysis method, the minimum inhibitory concentration is the lowest concentration at which growth is inhibited, and corresponds to a microtiter well in which the dye color is identical to that of a control group without culture and / or growth, or in which growth inhibition is confirmed by visual and / or optical inspection.
[0165] Examples
[0166] Example 1 : by pyraclostrobin combined with some exemplary C6-C10 unsaturated aliphatic acids (or agriculturally acceptable salts thereof) Fusarium oxysporumGrowth inhibition
[0167] Sample manufacturing:
[0168] 10 mg of pyraclostrobin (available as stock #229020 from Santa Cruz Biotechnology, Dallas, Texas) was dissolved in 10 mL of dimethyl sulfoxide (DMSO), and the resulting solution was diluted 2-fold in DMSO to provide a concentration of 0.5 mg / mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to provide a concentration of 0.05 mg / mL in 10% DMSO / 90% PDB. The solubility of pyraclostrobin in 10% DMSO / 90% PDB was determined to be 0.0154 mg / mL using high-performance liquid chromatography (HPLC).
[0169] A solution of (2E,4E)-2,4-hexadienoic acid, potassium salt was prepared by dissolving 2 g of (2E,4E)-2,4-hexadienoic acid, potassium salt in 20 mL of PDB and further diluting it by sequentially diluting it within the PDB. A solution of (2E,4E)-2,4-hexadienoic acid (available as stock #W342904 from Sigma-Aldrich) was prepared by dissolving 20 mg of (2E,4E)-2,4-hexadienoic acid in 1 mL of DMSO and adding 0.1 mL to 0.9 mL of PDB to produce a 2 mg / mL solution of (2E,4E)-2,4-hexadienoic acid in 10% DMSO / 90% PDB and further diluting it by sequentially diluting it within the PDB.
[0170] 100 mg of trans-2-hexene acid was dissolved in 1 mL of DMSO, and 0.1 mL to 0.9 mL of PDB was added to produce a 10 mg / mL solution in 10% DMSO / 90% PDB. A solution of trans-2-hexene acid (available from Sigma-Aldrich as stock #W316903) was prepared by further diluting this solution sequentially within the PDB. 20 μL of trans-3-hexene acid was added to 1980 μL of PDB, and a solution of trans-3-hexene acid (available from Sigma-Aldrich as stock #W317004) was prepared by sequentially diluting the resulting solution within the PDB. The density of trans-3-hexene acid was assumed to be 0.963 g / mL.
[0171] Pyraclostrobin and at least one exemplary C6-C10 saturated or unsaturated aliphatic acid (and an agronomically acceptable salt thereof) by adding 0.5 mL of 0.0308 mg / mL pyraclostrobin to 0.5 mL of 1.25 mg / mL (2E,4E)-2,4-hexadienoic acid, potassium salt (Combination 1), to 0.5 mL of 0.25 mg / mL (2E,4E)-2,4-hexadienoic acid (Combination 2), to 0.5 mL of 0.625 mg / mL (2E,4E)-2,4-hexadienoic acid (Combination 3), to 0.5 mL of 1.25 mg / mL trans-2-hexenoic acid (Combination 4), or to 0.5 mL of 0.6019 mg / mL trans-3-hexenoic acid (Combination 5). Combinations were prepared. Each combination was tested over a 2-fold dilution range in the synergistic growth inhibition assay described above, observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Table 1 below.
[0172] [Table 1]
[0173] by pyraclostrobin combined with some exemplary unsaturated aliphatic acids (or agriculturally acceptable salts thereof) Fusarium oxysporum Inhibition of growth.
[0174]
[0175] Example 2 : by fludioxonil combined with some exemplary unsaturated aliphatic acids (or agriculturally acceptable salts thereof) Fusarium oxysporum Inhibition of growth.
[0176] Sample manufacturing:
[0177] 20 mg of fludioxonil (available from Shanghai Terppon Chemical Co. Ltd. in Shanghai, China) was dissolved in 10 mL of dimethyl sulfoxide (DMSO), and the resulting solution was diluted 2-fold in DMSO to provide a concentration of 1 mg / mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to provide a concentration of 0.1 mg / mL in 10% DMSO / 90% PDB. The solubility of fludioxonil in 10% DMSO / 90% PDB was determined to be 0.0154 mg / mL using HPLC.
[0178] A solution of (2E,4E)-2,4-hexadienoic acid, potassium salt was prepared by dissolving 2 g of (2E,4E)-2,4-hexadienoic acid, potassium salt in 20 mL of PDB and further diluting it by sequentially diluting it within the PDB. A solution of (2E,4E)-2,4-hexadienoic acid (available as #W342904 from Sigma-Aldrich) was prepared by dissolving 20 mg of (2E,4E)-2,4-hexadienoic acid in 1 mL of DMSO and adding 0.1 mL to 0.9 mL of PDB to produce a 2 mg / mL solution of (2E,4E)-2,4-hexadienoic acid in 10% DMSO / 90% PDB and further diluting it by sequentially diluting it within the PDB.
[0179] 100 mg of trans-2-hexene acid was dissolved in 1 mL of DMSO, and 0.1 mL to 0.9 mL of PDB was added to produce a 10 mg / mL solution in 10% DMSO / 90% PDB. A solution of trans-2-hexene acid (available from Sigma-Aldrich as stock #W316903) was prepared by further diluting this solution sequentially within the PDB. 20 μL of trans-3-hexene acid was added to 1980 μL of PDB, and a solution of trans-3-hexene acid (available from Sigma-Aldrich as stock #W317004) was prepared by sequentially diluting the resulting solution within the PDB. The density of trans-3-hexene acid was assumed to be 0.963 g / mL.
[0180] Combinations of compounds A and B as shown in Table 2 below were prepared by adding 0.5 mL of 9.63 x 10⁻⁴ mg / mL fludioxonil to 0.5 mL of 0.625 mg / mL (2E,4E)-2,4-hexadienoic acid, potassium salt (Combination 1), to 0.5 mL of 0.25 mg / mL (2E,4E)-2,4-hexadienoic acid (Combination 2), to 0.5 mL of 0.625 mg / mL trans-2-hexenoic acid (Combination 3), and to 0.5 mL of 0.6019 mg / mL trans-3-hexenoic acid (Combination 4). Each combination was tested across a 2-fold dilution range in the synergistic growth inhibition assay, observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Table 2 below.
[0181] [Table 2]
[0182] fludioxonil in combination with some exemplary unsaturated aliphatic acids (or agriculturally acceptable salts thereof) Fusarium oxysporum Inhibition of growth.
[0183]
[0184] Example 3: by fludioxonil combined with some exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition:
[0185] Sample manufacturing:
[0186] 20 mg of fludioxonil (available from Shanghai Terpon Chemical Company Limited, Shanghai, China) was dissolved in 10 mL of dimethyl sulfoxide (DMSO), and the resulting solution was diluted 2-fold in DMSO to provide a concentration of 1 mg / mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to provide a concentration of 0.1 mg / mL in 10% DMSO / 90% PDB. The solubility of fludioxonil in 10% DMSO / 90% PDB was determined to be 0.0154 mg / mL using HPLC.
[0187] For each of 3-octenic acid (available from Sigma-Aldrich as stock #CDS000466), trans-2-octenic acid (available from Sigma-Aldrich), 9-decenoic acid (available from Sigma-Aldrich as #W366005), 3-decenoic acid (available from Sigma-Aldrich as stock #CDS000299), and trans-2-decenoic acid (available from TCI America as stock #D0098), 25 µL of each compound B was added to 975 µL of DMSO, and then diluted 10-fold in PDB to prepare a mother liquor of some exemplary C6-C10 unsaturated aliphatic acids as compound B for testing individual MICs at 25 µL / mL in DMSO.
[0188] To test in combination with fludioxonil, solutions of 3-octenic acid, trans-2-octenic acid, and 9-decenoic acid were prepared at a concentration of 0.78 uL / mL in DMSO by adding 3.125 uL of each compound B to 2 mL of DMSO and then diluting 2-fold in DMSO to provide 0.78 uL / mL. Solutions of 3-decenoic acid and trans-2-decenoic acid were prepared similarly, but with an additional 2-fold dilution in DMSO to provide a concentration of 0.39 uL / mL in DMSO.
[0189] Subsequently, each of these generated mother liquors was diluted 10-fold in PDB to provide a solution of 0.078 uL / mL for 3-octenic acid, trans-2-octenic acid, and 9-decenoic acid, respectively, and a solution of 0.039 uL / mL for 3-decenoic acid and trans-2-decenoic acid, respectively, all in 10% DMSO / 90% PDB.
[0190] 0.5 mL of 0.078 µL / mL 3-octenic acid, trans-2-octenic acid, and 9-decenoic acid, respectively, or 0.039 µL / mL 3-decenoic acid and trans-2-decenoic acid, 4.813 x 10⁶ obtained from sequential dilution using PDB of 0.0154 mg / mL fludioxonil in 10% DMSO / 90% PDB as prepared above. -4 A combination of exemplary compound B component and fludioxonil was prepared by adding it to 0.5 mL of mg / mL fludioxonil. The density of 3-octenic acid was assumed to be 0.938 g / mL. The density of trans-2-octenic acid was assumed to be 0.955 g / mL. The density of 3-decenoic acid was assumed to be 0.939 g / mL. The density of trans-2-decenoic acid was assumed to be 0.928 g / mL. The density of 9-decenoic acid was assumed to be 0.918 g / mL.
[0191] Each combination was tested across a 2-fold dilution range in the synergistic growth inhibition assay, observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Table 3 below.
[0192] [Table 3]
[0193] by fludioxonil combined with some exemplary unsaturated aliphatic acids Fusarium oxysporum Inhibition of growth.
[0194]
[0195] Example 4 : by combined thyme oil combined with some exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0196] Sample manufacturing:
[0197] 12.5 mg of thyme oil (available as stock #W306509 from Sigma-Aldrich) was dissolved in 1 g of dimethyl sulfoxide (DMSO), and the resulting solution was diluted 10-fold in PDB to provide a concentration of 1.25 mg / mL 10% DMSO / 90% PDB.
[0198] A mother liquor of several exemplary C6-C10 unsaturated aliphatic acids as Compound B for testing individual MICs was prepared at 25 μL / mL by adding 25 μL each of 3-octenic acid (available from Sigma-Aldrich as stock #CDS000466), trans-2-octenic acid (available from Sigma-Aldrich as stock #CDS000466), 9-decenoic acid (available from Sigma-Aldrich as stock #W366005), 3-decenoic acid (available from Sigma-Aldrich as stock #CDS000299), and trans-2-decenoic acid (available from TCI America as stock #D0098) to 975 μL of DMSO and then diluting 10-fold in PDB.
[0199] An exemplary mother liquor of a C6-C10 unsaturated aliphatic acid as Compound B to be tested in combination with thyme oil was prepared by adding 3.125 μL each of 3-octenic acid, trans-2-octenic acid, and 9-decenoic acid to 2 mL of DMSO and then diluting them 2-fold in DMSO to provide a mother liquor with a concentration of 0.78 μL / mL. Solutions of 3-decenoic acid and trans-2-decenoic acid were prepared similarly, but with an additional 2-fold dilution in DMSO to provide a concentration of 0.39 μL / mL.
[0200] Subsequently, each of these generated mother liquors was diluted 10-fold in PDB to provide a solution of 0.078 μL / mL in 10% DMSO / 90% PDB (for 3-octenic acid, trans-2-octenic acid, and 9-decenoic acid, respectively) and a solution of 0.039 μL / mL (for 3-decenoic acid and trans-2-decenoic acid).
[0201] Combinations of exemplary compound B component and thyme oil were prepared by adding 0.5 mL of 0.078 µL / mL 3-octenic acid, trans-2-octenic acid, and 9-decenoic acid, respectively, or 0.039 µL / mL 3-decenoic acid and trans-2-decenoic acid, respectively, to 0.5 mL of 1.25 mg / mL thyme oil in 10% DMSO / 90% PDB. The density of 3-octenic acid was assumed to be 0.938 g / mL. The density of trans-2-octenic acid was assumed to be 0.955 g / mL. The density of 3-decenoic acid was assumed to be 0.939 g / mL. The density of trans-2-decenoic acid was assumed to be 0.928 g / mL. The density of 9-decenoic acid was assumed to be 0.918 g / mL.
[0202] Each combination was tested across a 2-fold dilution range in the synergistic growth inhibition assay, observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Table 4 below.
[0203] [Table 4]
[0204] by thyme oil combined with some exemplary unsaturated aliphatic acids Fusarium oxysporum Inhibition of growth.
[0205]
[0206] Example 5 : by neem oil limonoid extract (derived from cold-pressed neem oil) and Fortune Aza Technical (azadirachtin extract) combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0207] Sample manufacturing:
[0208] A neem oil limonoid extract was prepared by preparing a limonoid extract from cold-pressed neem oil using solvent extraction with hexane and methanol. Fortune Aza Technical pesticide (extracted from neem seed / kernel sources) containing 14% azadirachtin was obtained from Fortune Biotech Ltd. in Secunderabad, India.
[0209] A solution of neem oil limonoid extract and Fortune Aza Technical was prepared at 5 mg / mL in DMSO and then diluted 10-fold in PDB to provide a concentration of 0.5 mg / mL in 10% DMSO / 90% PDB.
[0210] The mother liquor of 3-octenic acid and trans-2-octenic acid as compound B for testing individual MICs was prepared at 25 μL / mL by adding 25 μL of each compound B to 975 μL of DMSO and then diluting it 10-fold in PDB.
[0211] To test in combination with neem oil limonoid extract and Fortune Aza Technical, 62.5 μL of each compound was added to 937.5 μL of DMSO and diluted 10-fold in PDB (ratio 11.7) to prepare a mother liquor of 3-octenic acid and trans-2-octenic acid to a concentration of 6.25 μL / mL. To test in combination, 31.25 μL of each compound was added to 968.75 μL of DMSO and diluted 10-fold in PDB (ratio 6.0 or 5.9) to prepare a mother liquor of 3-octenic acid and trans-2-octenic acid to a concentration of 3.125 μL / mL. To test in combination, 6.25 μL of each compound was added to 993.75 μL of DMSO and diluted 10-fold in PDB (ratio 1.2) to prepare a mother liquor of 3-octenic acid and trans-2-octenic acid to a concentration of 0.625 μL / mL. The density of 3-octenic acid was assumed to be 0.938 g / mL. The density of trans-2-octenic acid was assumed to be 0.955 g / mL.
[0212] Combinations for testing by synergistic growth inhibition assay were prepared by adding 0.5 mL of the above-prepared 6.25 μL / mL, 3.125 μL / mL, or 0.625 μL / mL 3-octenic acid or trans-2-octenic acid (as Compound B) to 0.5 mg / mL of neem oil limonoid extract in 10% DMSO / 90% PDB or 0.5 mL of Fortune Aza Technical (as Compound A). Each combination was observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 5 and 6 below.
[0213] [Table 5]
[0214] by limonoid extracts from cold-pressed neem oil combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0215]
[0216] [Table 6]
[0217] by Fortune Aza Technical in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0218]
[0219] Example 6 : by fludioxonil combined with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0220] Sample manufacturing:
[0221] 20 mg of fludioxonil was dissolved in 10 mL of dimethyl sulfoxide (DMSO), and the resulting solution was diluted 2-fold in DMSO to provide a concentration of 1 mg / mL. This solution was diluted 10-fold in potato dextrose broth (PDB) to provide a concentration of 0.1 mg / mL in 10% DMSO / 90% PDB. The solubility of fludioxonil in 10% DMSO / 90% PDB was determined to be 0.0154 mg / mL using high-performance liquid chromatography. A solution of 0.000963 mg / mL fludioxonil was prepared by adding 625 μL of 0.0154 mg / mL fludioxonil to 9375 μL of PDB.
[0222] To test individual MICs, the mother liquor of hexanoic acid or octanoic acid as component B was prepared by adding 100 μL of hexanoic acid (93 mg) or octanoic acid (91 mg) to 900 μL of PDB to produce concentrations of 9.3 mg / mL and 9.1 mg / mL, respectively. The mother liquor of decanoic acid was prepared to 10 mg / mL in DMSO and then diluted 10-fold in PDB to produce a concentration of 1 mg / mL in 10% DMSO / 90% PDB. The mother liquor of decanoic acid, potassium salt, was prepared by adding 100 mg to 10 mL of PDB to produce a concentration of 10 mg / mL. The mother liquor of dodecanoic acid was prepared to 1 mg / mL in DMSO and then diluted 10-fold in PDB to produce a concentration of 0.1 mg / mL in 10% DMSO / 90% PDB.
[0223] To test the MIC of the combination, a solution of 0.29 mg / mL hexanoic acid was prepared by adding 156 μL of 9.3 mg / mL mother liquor to 4844 μL of PDB. Similarly, a solution of 1.14 mg / mL octanoic acid was prepared by diluting 9.1 mg / mL mother liquor in PDB. A solution of 0.5 mg / mL decanoic acid was prepared by 2-fold dilution of 1 mg / mL mother liquor. A solution of 0.156 mg / mL decanoic acid, potassium salt, was prepared by adding 78 μL of 10 mg / mL mother liquor to 4922 μL of PDB. A solution of 0.2 mg / mL dodecanoic acid was prepared by dissolving 2 mg in 1 mL of DMSO and then diluting it 10-fold in PDB at 40°C.
[0224] Combinations for the results shown in Table 7 were prepared by adding 0.5 mL of 0.0154 mg / mL fludioxonil to each of the 0.5 mL mother liquors. Each combination was tested over a 2-fold dilution range in the synergistic growth inhibition assay, observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Table 7 below.
[0225] [Table 7]
[0226] fludioxonil combined with various exemplary saturated aliphatic acids (and their salts) Fusarium oxysporum Inhibition of growth.
[0227]
[0228] Combinations for the results shown in Table 8 were prepared by adding 0.5 mL of 0.000963 mg / mL fludioxonil to each of the 0.5 mL mother liquors.
[0229] [Table 8]
[0230] fludioxonil in combination with various exemplary saturated aliphatic acids Fusarium oxysporum Inhibition of growth.
[0231]
[0232] Example 7 : Limonoid extracts from cold-pressed neem oil combined with various exemplary saturated aliphatic acids and Fortune Aza Technical (azadirachtin extract) Fusarium oxysporum Growth inhibition
[0233] Sample manufacturing:
[0234] Limonoid extracts were prepared from cold-pressed neem oil using solvent extraction with hexane and methanol. Fortune Aza Technical pesticide containing 14% azadirachtin (extracted from neem seed / kernel sources) was obtained from Fortune Biotech Limited in Secunderabad, India (also referred to as "Azatech"). Solutions of the neem oil limonoid extract and Fortune Aza Technical were prepared at 5 mg / mL in DMSO and then diluted 10-fold in PDB to provide a concentration of 0.5 mg / mL in 10% DMSO / 90% PDB. These solutions were used to test individual MICs.
[0235] To test the individual MIC of octanoic acid, a solution was prepared by adding 100 μL of octanoic acid (91 mg) to 900 μL of PDB to produce a concentration of 9.1 mg / mL. The mother liquor of decanoic acid was prepared at 10 mg / mL in DMSO and then diluted 10-fold in PDB to produce a concentration of 1 mg / mL in 10% DMSO / 90% PDB.
[0236] A combination with octanoic acid was prepared by dissolving 5 mg of neem oil limonoid extract or Fortune Aza Technical in 1 mL of DMSO, adding 6.25 μL of octanoic acid (d=0.91 g / mL), and diluting 10-fold in PDB. This produced a solution containing 0.5 mg / mL of neem oil limonoid extract or Fortune Aza Technical and 0.56875 mg / mL of octanoic acid. A combination with decanoic acid was prepared by dissolving 5 mg of neem oil limonoid extract or Fortune Aza Technical in 1 mL of DMSO, adding 2.5 mg of decanoic acid, and diluting 10-fold in PDB. This produced a solution containing 0.5 mg / mL of neem oil limonoid extract or Fortune Aza Technical and 0.25 mg / mL of decanoic acid.
[0237] Each combination was tested across a 2-fold dilution range in the synergistic growth inhibition assay, observed after a 24-hour incubation period, and the FIC index for each combination was calculated as shown in Table 9 below.
[0238] [Table 9]
[0239] Neem oil limonoid extracts combined with various exemplary saturated aliphatic acids or by Fortune Aza Technical (AzaTech) Fusarium oxysporum Growth inhibition
[0240]
[0241] Sample preparation for Examples 8 to 19
[0242] For each of the experimental examples 8 to 19 described below, a concentrated mother liquor and a diluted working solution were prepared for each of the exemplary pesticide active ingredient as Component A and each of the exemplary unsaturated and saturated aliphatic acids as Component B, in accordance with the following description:
[0243] Compound A pesticide active ingredient:
[0244] A concentrated mother liquor was prepared by dissolving the pesticide active ingredient in 100% dimethyl sulfoxide (DMSO), and then the mother liquor was diluted 10-fold in potato dextrose broth (PDB) to provide a working mother liquor as described below:
[0245] Pyraclostrobin (available as stock #SC-229020 from Santa Cruz Biotech, Dallas, Texas, USA): A 0.5 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.05 mg / mL working stock solution, to which an effective soluble concentration of 0.015 mg / mL was determined using high-performance liquid chromatography (HPLC). This 0.015 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0246] Azoxystrobin (available as Stock #31697 from Sigma-Aldrich, St. Louis, Missouri, USA): A stock solution of 1.75 mg / mL in 100% DMSO was diluted 10-fold in PDB to provide a nominal working stock solution of 0.175 mg / mL, to which an effective soluble concentration of 0.15 mg / mL was determined using high-performance liquid chromatography (HPLC). This working stock solution with an effective concentration of 0.15 mg / mL was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0247] Chlorothalonil (available as Stock #N-11454 from Chem Service Inc., Westchester, Pennsylvania, USA): A 0.5 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.05 mg / mL working stock solution, to which an effective soluble concentration of 0.002 mg / mL was determined using high-performance liquid chromatography (HPLC). This 0.002 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0248] Fludioxonil (available from Shanghai Terpon Chemical Company Limited, Shanghai, China): A 1.05 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.105 mg / mL working stock solution, to which an effective soluble concentration of 0.021 mg / mL was confirmed using high-performance liquid chromatography (HPLC). This 0.021 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0249] Cyprodinyl (available from Shanghai Terpon Chemical Company Limited, Shanghai, China): A 1.37 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.137 mg / mL working stock solution, to which an effective soluble concentration of 0.009 mg / mL was confirmed using high-performance liquid chromatography (HPLC). This 0.009 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0250] Metalaxyl: A 3.32 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.332 mg / mL working stock solution, and an effective soluble concentration of 0.316 mg / mL was confirmed using high-performance liquid chromatography (HPLC). This 0.316 mg / mL effective concentration working stock solution was used for further sequential dilution in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0251] Diphenoconazole (available under stock number SC-204721 from Santa Cruz Biotech, Dallas, Texas, USA): A 1.3 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.13 mg / mL working stock solution, to which an effective soluble concentration of 0.051 mg / mL was determined using high-performance liquid chromatography (HPLC). This 0.051 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0252] Propiconazole (available from Shanghai Terpon Chemical Company Limited, Shanghai, China): A 1.0 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.10 mg / mL working stock solution, to which an effective soluble concentration of 0.089 mg / mL was determined using high-performance liquid chromatography (HPLC). This 0.089 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0253] Epoxyconazole (available from Shanghai Terpon Chemical Company Limited, Shanghai, China): A 2.5 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.25 mg / mL working stock solution, to which an effective soluble concentration of 0.03 mg / mL was confirmed using high-performance liquid chromatography (HPLC). This 0.025 mg / mL effective concentration working stock solution was used for further sequential dilution in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0254] Tebuconazole (available from Shanghai Terpon Chemical Company Limited, Shanghai, China): A 5.0 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a nominal 0.50 mg / mL working stock solution, to which an effective soluble concentration of 0.45 mg / mL was confirmed using high-performance liquid chromatography (HPLC). This 0.45 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0255] Thyme oil (available as stock #W306509 from Sigma-Aldrich, St. Louis, Missouri, USA), Garlic oil (available from New Directions Aromatics, Mississauga, Ontario, Canada), Lemongrass oil (available as stock #OL123 from Xenex Labs, Coquitlam, British Columbia, Canada), Wintergreen oil (available as stock #OW134 from Xenex Labs, Coquitlam, British Columbia, Canada), Peppermint oil (available as stock #OP1531 from Xenex Labs, Coquitlam, British Columbia, Canada), Spearmint oil (available as stock #AS132 from Xenex Labs, Coquitlam, British Columbia, Canada), Clove leaf oil (New (Available from Directions Aromatics), cinnamon leaf oil (available as stock #OC2131 from Genex Labs, Coquitlam, British Columbia, Canada), tea tree oil (available from Newco Natural Technology, Calgary, Alberta, Canada), geranium oil (available as stock #OW134 from Genex Labs, Coquitlam, British Columbia, Canada), peppermint oil (available as stock #OG1042 from Genex Labs, Coquitlam, British Columbia, Canada), rosemary oil (available as stock #OR131 from Genex Labs, Coquitlam, British Columbia, Canada), and oregano oil (available from New Directions Aromatics, Mississauga, Ontario, Canada): 100 mg / mL mother liquor in 100% DMSO in PDB A working stock solution with a concentration of 10 mg / mL was provided by diluting it 10-fold. This working stock solution with an effective concentration of 10 mg / mL was used for further sequential dilution of the PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0256] Nootcarton(+) (available as stock #A19166 from Alfa Aesar, Ward Hill, Massachusetts, USA): A 10 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution at a concentration of 1.0 mg / mL. This 1.0 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 through 111 below.
[0257] Neem oil limonoid extract: A neem oil limonoid extract was prepared by preparing a limonoid extract from cold-pressed neem oil using solvent extraction with hexane and methanol. A neem oil limonoid extract stock solution of 5 mg / mL in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution with a concentration of 0.5 mg / mL. This working stock solution with an effective concentration of 0.5 mg / mL was used for further sequential dilution in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0258] Fortune Aza Technical: Fortune Aza Technical containing 14% azadirachtin TM The pesticide (extracted from a neem seed / kernel source) was obtained from Fortune Biotech Limited in Secunderabad, India. A 5 mg / mL Fortune Aza Technical stock solution in 100% DMSO was diluted 10-fold in the PDB to provide a working stock solution at a concentration of 0.5 mg / mL. This 0.5 mg / mL effective concentration working stock solution was used for further sequential dilutions in the PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0259] Caranja oil flavonoid extract: Flavonoid extracts were prepared from cold-pressed caranja oil by solvent extraction. A 5 mg / mL caranja oil flavonoid extract stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution at a concentration of 0.5 mg / mL. This 0.5 mg / mL effective concentration working stock solution was used for further sequential dilution in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0260] Salanine: Salanine was extracted and purified from cold-pressed neem oil by solvent extraction. A 1 mg / mL salanine mother liquor in 100% DMSO was diluted 10-fold in PDB to provide a working mother liquor with a concentration of 0.1 mg / mL. This 0.1 mg / mL effective concentration working mother liquor was used for further sequential dilution in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0261] Compound B unsaturated aliphatic acid:
[0262] A concentrated mother liquor was prepared by dissolving each exemplary unsaturated aliphatic acid in 100% dimethyl sulfoxide (DMSO), and then diluted 10-fold in potato dextrose broth (PDB) to provide a working mother liquor as described below:
[0263] Trans-2-hexene, trans-3-hexene, cis-3-hexene, 5-hexene, 3-heptene, trans-2-octene, trans-3-octene, 3-octene, 7-octene, 3-decene, cis-3-decene, 9-decene, trans-2-nonene, 3-nonene, (9Z)-octadecene (oleic acid) (all available from Sigma-Aldrich, St. Louis, Missouri, USA), trans-2-decene (available as stock #D0098 from TCI America, Portland, Oregon, USA), cis-2-decene (available from BOC Sciences, Sully, New York, USA), and trans-2-undecene (stock from Alpha Eisa, Ward Hill, Massachusetts, USA). A 50 mg / mL stock solution in 100% DMSO was diluted 10-fold in PDB to provide a working stock solution at a concentration of 5 mg / mL. This 5 mg / mL effective concentration working stock solution was used for further sequential dilutions in PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0264] (2E,4E)-2,4-hexadienoic acid (available from Sigma-Aldrich, St. Louis, Missouri, USA): A 20 mg / mL stock solution in 100% DMSO was diluted 10-fold in the PDB to provide a working stock solution at a concentration of 2 mg / mL. This 2 mg / mL effective concentration working stock solution was used for further sequential dilutions in the PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0265] Compound B Saturated aliphatic acid:
[0266] A concentrated mother liquor was prepared by dissolving each exemplary saturated aliphatic acid in 100% dimethyl sulfoxide (DMSO), and then diluted 10-fold in potato dextrose broth (PDB) to provide a working mother liquor as described below:
[0267] Hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid (all available from Sigma-Aldrich, St. Louis, Missouri, USA): A 50 mg / mL stock solution in 100% DMSO was diluted 10-fold in the PDB to provide a working stock solution at a concentration of 5 mg / mL. This 5 mg / mL effective concentration working stock solution was used for further sequential dilutions in the PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0268] Decenoic acid (available from Sigma-Aldrich, St. Louis, Missouri, USA): A 10 mg / mL stock solution in 100% DMSO was diluted 10-fold in the PDB to provide a working stock solution at a concentration of 1 mg / mL. This 1 mg / mL effective concentration working stock solution was used for further sequential dilutions in the PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0269] Dodecenoic acid (available from Sigma-Aldrich, St. Louis, Missouri, USA): A 1 mg / mL stock solution in 100% DMSO was diluted 10-fold in the PDB to provide a working stock solution at a concentration of 0.1 mg / mL. This 0.1 mg / mL effective concentration working stock solution was used for further sequential dilutions in the PDB to the required individual concentrations specified in Tables 10 to 111 below.
[0270] Next, the working stocks for each component of compound A and compound B were sequentially diluted, and according to the synergistic growth inhibition analysis described above, the individual MICs of each pesticide active component (as compound A), each unsaturated or saturated aliphatic acid (as compound B), and the combined MICs of each combination of compound A and compound B were tested.
[0271] Example 8 : by pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, cyprodinil, difenoconazole, and tebuconazole in combination with various exemplary saturated aliphatic acids Fusarium oxysporumGrowth inhibition
[0272] Working solutions of pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, cyprodinil, diphenoconazole, and tebuconazole were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 10 to 15 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, and decanoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 10 to 15 below.
[0273] Each individual compound and combination was tested across a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 48-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 10 to 15 below.
[0274] [Table 10]
[0275] by pyraclostrobin combined with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0276]
[0277] [Table 11]
[0278] azoxystrobin in combination with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0279]
[0280] [Table 12]
[0281] by chlorothalonil in combination with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0282]
[0283] [Table 13]
[0284] fludioxonil and cyprodinil in combination with exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0285]
[0286] [Table 14]
[0287] diphenoconazole in combination with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0288]
[0289] [Table 15]
[0290] by tebuconazole combined with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0291]
[0292] Example 9 : by pyraclostrobin, azoxystrobin, propiconazole, epiconazole, tebuconazole, and diphenoconazole in combination with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0293] Working solutions of pyraclostrobin, azoxystrobin, propiconazole, epiconazole, tebuconazole, and diphenoconazole were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 16 to 20 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 16 to 20 below.
[0294] Each individual compound and combination was tested over a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 7-day incubation period, and the FIC index for each combination was calculated as shown in Tables 16 to 20 below.
[0295] [Table 16]
[0296] by pyraclostrobin combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0297]
[0298] [Table 17]
[0299] azoxystrobin in combination with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0300]
[0301] [Table 18]
[0302] propiconazole in combination with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0303]
[0304] [Table 19]
[0305] by epiconazole and tebuconazole in combination with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0306]
[0307] [Table 20]
[0308] diphenoconazole in combination with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0309]
[0310] Example 10: by pyraclostrobin, azoxystrobin, cyprodinyl, metalaxyl, epiconazole, tebuconazole, propiconazole, and diphenoconazole in combination with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0311] Working solutions of pyraclostrobin, azoxystrobin, cyprodinyl, metalaxyl, epiconazole, tebuconazole, propiconazole, and diphenoconazole were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 21 to 26 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 21 to 26 below.
[0312] Each individual compound and combination was tested across a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 48-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 21 to 26 below.
[0313] [Table 21]
[0314] by pyraclostrobin combined with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0315]
[0316] [Table 22]
[0317] azoxystrobin in combination with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0318]
[0319] [Table 23]
[0320] by pyraclostrobin, cyprodinyl, metalaxyl, azoxystrobin, epoxyconazole, and tebuconazole in combination with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0321]
[0322] [Table 24]
[0323] diphenoconazole and propiconazole in combination with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0324]
[0325] [Table 25]
[0326] by tebuconazole combined with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0327]
[0328] [Table 26]
[0329] by cyprodinyl and metalaxyl combined with various exemplary saturated aliphatic acids Botrytis Cinerea Growth inhibition
[0330]
[0331] Example 11 : by pyraclostrobin, azoxystrobin, fludioxonil, cyprodinil, diphenoconazole, epoxyconazole, and tebuconazole in combination with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0332] Working solutions of pyraclostrobin, azoxystrobin, fludioxonil, cyprodinil, diphenoconazole, epoxyconazole, and tebuconazole were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for the MIC test shown in Tables 27 to 32 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-3-hexenoic acid, 4-hexenoic acid, 5-hexenoic acid, 3-hepteneic acid, trans-2-octenic acid, trans-3-octenic acid, 7-octenic acid, 3-deceneic acid, 9-deceneic acid, trans-2-noneneic acid, 3-noneneic acid, trans-2-deceneic acid, and trans-2-undecenoic acid (as Compound B) were each prepared as described above and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 27 to 32 below.
[0333] Each individual compound and combination was tested across a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 48-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 27 to 32 below.
[0334] [Table 27]
[0335] by pyraclostrobin in combination with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0336]
[0337] [Table 28]
[0338] by azoxystrobin in combination with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0339]
[0340] [Table 29]
[0341] fludioxonil and cyprodinil in combination with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0342]
[0343] [Table 30]
[0344] by diphenoconazole in combination with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0345]
[0346] [Table 31]
[0347] by epoxyconazole combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0348]
[0349] [Table 32]
[0350] by tebuconazole combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0351]
[0352] Example 12 : by pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, diphenoconazole, propiconazole, epoxyconazole, and tebuconazole in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0353] Working solutions of pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, diphenoconazole, propiconazole, epoxyconazole, and tebuconazole were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for the MIC test shown in Tables 33 to 42 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenoic acid, trans-3-hexenoic acid, 5-hexenoic acid, 3-hepteneic acid, trans-2-octenic acid, trans-3-octenic acid, 3-octenic acid, 7-octenic acid, 3-decenoic acid, cis-3-hexenoic acid, 9-decenoic acid, trans-2-noneneic acid, 3-noneneic acid, (9Z)-octadecenoic acid, trans-2-decenoic acid, cis-2-decenoic acid, and trans-2-undecenoic acid were each prepared (as Compound B) as described above and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 33 to 42 below.
[0354] Each individual compound and combination was tested over a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 7-day incubation period, and the FIC index for each combination was calculated as shown in Tables 33 to 42 below.
[0355] [Table 33]
[0356] by pyraclostrobin in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0357]
[0358] [Table 34]
[0359] by pyraclostrobin in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0360]
[0361] [Table 35]
[0362] by azoxystrobin in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0363]
[0364] [Table 36]
[0365] by chlorothalonil in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0366]
[0367] [Table 37]
[0368] by fludioxonil in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0369]
[0370] [Table 38]
[0371] by diphenoconazole in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0372]
[0373] [Table 39]
[0374] propiconazole in combination with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0375]
[0376] [Table 40]
[0377] by epoxyconazole combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0378]
[0379] [Table 41]
[0380] by tebuconazole combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0381]
[0382] [Table 42]
[0383] by tebuconazole combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0384]
[0385] Example 13 : by pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinyl, metalaxyl, epoxyconazole, and tebuconazole in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0386] Working solutions of pyraclostrobin, azoxystrobin, chlorothalonil, cyprodinil, metalaxyl, epoxyconazole, and tebuconazole were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for the MIC test shown in Tables 43 to 50 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenoic acid, trans-3-hexenoic acid, 5-hexenoic acid, 3-hepteneic acid, trans-2-octenic acid, trans-3-octenic acid, 3-octenic acid, 7-octenic acid, 3-deceneic acid, 9-deceneic acid, trans-2-noneneic acid, 3-noneneic acid, (9Z)-octadeceneic acid, trans-2-deceneic acid, and trans-2-undecenoic acid (as Compound B) were each prepared as described above and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 43 to 50 below.
[0387] Each individual compound and combination was tested across a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 48-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 43 to 50 below.
[0388] [Table 43]
[0389] by pyraclostrobin in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0390]
[0391] [Table 44]
[0392] by pyraclostrobin in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0393]
[0394] [Table 45]
[0395] by azoxystrobin in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0396]
[0397] [Table 46]
[0398] by chlorothalonil in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0399]
[0400] [Table 47]
[0401] by cyprodinyl in combination with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0402]
[0403] [Table 48]
[0404] by metalaxyl combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0405]
[0406] [Table 49]
[0407] by epoxyconazole combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0408]
[0409] [Table 50]
[0410] by tebuconazole combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0411]
[0412] Example 14 : by thyme oil, garlic oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, tea tree oil, oregano oil, nootcartone(+), and Fortune Aza Technical (also known as Fortune AzaTech) azadirachtin extract combined with various exemplary saturated aliphatic acids Fusarium oxysporum Inhibition of growth.
[0413] Working solutions of thyme oil, garlic oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, tea tree oil, oregano oil, Nootkaton(+), and Fortune Aza Technical (also known as Fortune Aza Tech) azadirachtin extract were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 51 to 61 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 51 to 61 below.
[0414] Each individual compound and combination was tested over a 2-fold dilution range in a synergistic growth inhibition assay, observed after an incubation period of 24 hours or 4 days as specified below, and the FIC index for each combination was calculated as shown in Tables 51 to 61 below.
[0415] [Table 51]
[0416] by thyme oil combined with various exemplary saturated aliphatic acids, observed after 24 hours of incubation Fusarium oxysporum Growth inhibition
[0417]
[0418] [Table 52]
[0419] garlic oil combined with various exemplary saturated aliphatic acids, observed after 24 hours of incubation Fusarium oxysporum Growth inhibition
[0420]
[0421] [Table 53]
[0422] by wintergreen oil combined with various exemplary saturated aliphatic acids, observed after 24 hours of incubation Fusarium oxysporum Growth inhibition
[0423]
[0424] [Table 54]
[0425] Peppermint oil combined with various exemplary saturated aliphatic acids, observed after 4 days of incubation Fusarium oxysporum Growth inhibition
[0426]
[0427] [Table 55]
[0428] Spearmint oil combined with various exemplary saturated aliphatic acids, observed after 4 days of incubation Fusarium oxysporum Growth inhibition
[0429]
[0430] [Table 56]
[0431] clove leaf oil combined with various exemplary saturated aliphatic acids, observed after 4 days of incubation Fusarium oxysporum Growth inhibition
[0432]
[0433] [Table 57]
[0434] by tea tree oil combined with various exemplary saturated aliphatic acids, observed after 4 days of incubation Fusarium oxysporum Growth inhibition
[0435]
[0436] [Table 58]
[0437] oregano oil combined with various exemplary saturated aliphatic acids, observed after 4 days of incubation Fusarium oxysporum Growth inhibition
[0438]
[0439] [Table 59]
[0440] oregano oil combined with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0441]
[0442] [Table 60]
[0443] by nootkaton(+) combined with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0444]
[0445] [Table 61]
[0446] By Fortune Aza Technical, combined with various exemplary saturated aliphatic acids Fusarium oxysporum Growth inhibition
[0447]
[0448] Example 15 : Thyme oil, garlic oil, lemongrass oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, cinnamon leaf oil, rosemary oil, oregano oil, neem oil limonoid extract, and salanin combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Inhibition of growth.
[0449] Working solutions of thyme oil, garlic oil, lemongrass oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, cinnamon leaf oil, rosemary oil, oregano oil, neem oil limonoid extract, and salanin were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 62 to 73 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 62 to 73 below.
[0450] Each individual compound and combination was tested over a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 7-day incubation period, and the FIC index for each combination was calculated as shown in Tables 62 to 73 below.
[0451] [Table 62]
[0452] thyme oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0453]
[0454] [Table 63]
[0455] by garlic oil combined with various exemplary saturated fatty acids Slerotinia slerothiorum Growth inhibition
[0456]
[0457] [Table 64]
[0458] by lemongrass oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0459]
[0460] [Table 65]
[0461] by wintergreen oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0462]
[0463] [Table 66]
[0464] by peppermint oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0465]
[0466] [Table 67]
[0467] by spearmint oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0468]
[0469] [Table 68]
[0470] clove leaf oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0471]
[0472] [Table 69]
[0473] by cinnamon leaf oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0474]
[0475] [Table 70]
[0476] by rosemary oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0477]
[0478] [Table 71]
[0479] oregano oil combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0480]
[0481] [Table 72]
[0482] by neem oil limonoid extracts combined with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0483]
[0484] [Table 73]
[0485] salanine in combination with various exemplary saturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0486]
[0487] Example 16 : by thyme oil, wintergreen oil, spearmint oil, rosemary oil, oregano oil, Nootkatone(+), caranza oil flavonoid extract, Fortune Aza Technical, salanin, and neem oil limonoid extract combined with various exemplary saturated aliphatic acids Botrytis Cinerea Inhibition of growth.
[0488] Working solutions of thyme oil, wintergreen oil, spearmint oil, rosemary oil, oregano oil, nootkaton(+), caranza oil flavonoid extract, Fortune Aza Technical, salanin, and neem oil limonoid extract were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 74 to 83 below. Working solutions of hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, and dodecanoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 74 to 83 below.
[0489] Each individual compound and combination was tested over a 2-fold dilution range in the growth inhibition assay, observed after an incubation period of 24 hours to 4 days as mentioned, and the FIC index for each combination was calculated as shown in Tables 74 to 83 below.
[0490] [Table 74]
[0491] by thyme oil combined with various exemplary saturated aliphatic acids, observed after 4 days of incubation Botrytis Cinerea Growth inhibition
[0492]
[0493] [Table 75]
[0494] by wintergreen oil combined with various exemplary saturated aliphatic acids, observed after 24 hours of incubation Botrytis Cinerea Growth inhibition
[0495]
[0496] [Table 76]
[0497] Spearmint oil combined with various exemplary saturated aliphatic acids observed after 4 days of incubation Botrytis Cinerea Growth inhibition
[0498]
[0499] [Table 77]
[0500] rosemary oil combined with various exemplary saturated aliphatic acids observed after 48 hours of incubation Botrytis Cinerea Growth inhibition
[0501]
[0502] [Table 78]
[0503] oregano oil combined with various exemplary saturated aliphatic acids observed after 24 hours of incubation Botrytis Cinerea Growth inhibition
[0504]
[0505] [Table 79]
[0506] Nootkaton(+) in combination with various exemplary saturated aliphatic acids observed after 48 hours of incubation Botrytis Cinerea Growth inhibition
[0507]
[0508] [Table 80]
[0509] by caranza oil flavonoid extract combined with various exemplary saturated aliphatic acids observed after 48 hours of incubation Botrytis Cinerea Growth inhibition
[0510]
[0511] [Table 81]
[0512] By Fortune Aza Technical, combined with various exemplary saturated aliphatic acids, observed after 48 hours of incubation Botrytis Cinerea Growth inhibition
[0513]
[0514] [Table 82]
[0515] by salanin combined with various exemplary saturated aliphatic acids observed after 48 hours of incubation Botrytis Cinerea Growth inhibition
[0516]
[0517] [Table 83]
[0518] by neem oil limonoid extracts combined with various exemplary saturated aliphatic acids, observed after 24 hours of incubation Botrytis Cinerea Growth inhibition
[0519]
[0520] Example 17: by thyme oil, garlic oil, lemongrass oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, cinnamon leaf oil, tea tree oil, geranium oil, oregano oil, rosemary oil, and nootkaton(+) combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Inhibition of growth.
[0521] Working solutions of thyme oil, garlic oil, lemongrass oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, cinnamon leaf oil, tea tree oil, geranium oil, oregano oil, rosemary oil, and Nootkaton(+) were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 84 to 98 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenoic acid, trans-3-hexenoic acid, 4-hexenoic acid, 5-hexenoic acid, 3-hepteneic acid, trans-2-octenic acid, trans-3-octenic acid, 3-octenic acid, 7-octenic acid, 3-deceneic acid, 9-deceneic acid, trans-2-noneneic acid, 3-noneneic acid, (9Z)-octadeceneic acid, trans-2-deceneic acid, and trans-2-undecenoic acid were each prepared (as Compound B) as described above and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 84 to 98 below.
[0522] Each individual compound and combination was tested across a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 48-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 84 to 98 below.
[0523] [Table 84]
[0524] by thyme oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0525]
[0526] [Table 85]
[0527] by thyme oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0528]
[0529] [Table 86]
[0530] by garlic oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0531]
[0532] [Table 87]
[0533] by lemongrass oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0534]
[0535] [Table 88]
[0536] by wintergreen oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0537]
[0538] [Table 89]
[0539] by peppermint oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0540]
[0541] [Table 90]
[0542] by spearmint oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0543]
[0544] [Table 91]
[0545] clove leaf oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0546]
[0547] [Table 92]
[0548] by cinnamon leaf oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0549]
[0550] [Table 93]
[0551] by tea tree oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0552]
[0553] [Table 94]
[0554] by geranium oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0555]
[0556] [Table 95]
[0557] by oregano oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0558]
[0559] [Table 96]
[0560] by oregano oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0561]
[0562] [Table 97]
[0563] by rosemary oil combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0564]
[0565] [Table 98]
[0566] by nootkaton(+) combined with various exemplary unsaturated aliphatic acids Fusarium oxysporum Growth inhibition
[0567]
[0568] Example 18 : by thyme oil, garlic oil, lemongrass oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, Fortune Aza Technical Azadirachtin extract, and oregano oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Inhibition of growth.
[0569] Working solutions of thyme oil, garlic oil, lemongrass oil, wintergreen oil, peppermint oil, spearmint oil, clove leaf oil, Fortune Aza Technical Azadirachtin extract, and oregano oil were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 99 to 107 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenoic acid, trans-3-hexenoic acid, 4-hexenoic acid, 5-hexenoic acid, 3-hepteneic acid, trans-2-octenic acid, trans-3-octenic acid, 3-octenic acid, 7-octenic acid, 3-deceneic acid, 9-deceneic acid, trans-2-noneneic acid, 3-noneneic acid, (9Z)-octadeceneic acid, trans-2-deceneic acid, and trans-2-undecenoic acid were each prepared (as Compound B) as described above and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 99 to 107 below.
[0570] Each individual compound and combination was tested over a 2-fold dilution range in a synergistic growth inhibition assay, observed after a 7-day incubation period, and the FIC index for each combination was calculated as shown in Tables 99 to 107 below.
[0571] [Table 99]
[0572] by thyme oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0573]
[0574] [Table 100]
[0575] by garlic oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0576]
[0577] [Table 101]
[0578] by lemongrass oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0579]
[0580] [Table 102]
[0581] by wintergreen oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0582]
[0583] [Table 103]
[0584] by peppermint oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0585]
[0586] [Table 104]
[0587] by spearmint oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0588]
[0589] [Table 105]
[0590] clove leaf oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorumGrowth inhibition
[0591]
[0592] [Table 106]
[0593] By Fortune Aza Technical, combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0594]
[0595] [Table 107]
[0596] by oregano oil combined with various exemplary unsaturated aliphatic acids Slerotinia slerothiorum Growth inhibition
[0597]
[0598] Example 19 : by oregano oil, nootcartone(+), spearmint oil, rosemary oil, thyme oil, salanine, caranza oil flavonoid extract, and neem oil limonoid extract combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Inhibition of growth.
[0599] Working solutions of oregano oil, nootkatone(+), spearmint oil, rosemary oil, thyme oil, salanine, caranja oil flavonoid extract, and neem oil limonoid extract were each prepared as described above (as Compound A) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 108 to 115 below. Working solutions of (2E,4E)-2,4-hexadienoic acid, trans-2-hexenic acid, trans-3-hexenic acid, 5-hexenic acid, trans-2-octenic acid, 7-octenic acid, 3-decenoic acid, 9-decenoic acid, and trans-2-decenoic acid were each prepared as described above (as Compound B) and sequentially diluted in PDB to the individual required concentrations for MIC testing shown in Tables 108 to 115 below.
[0600] Each individual compound and combination was tested over a 2-fold dilution range in the growth inhibition assay, observed after a 48-hour incubation period, and the FIC index for each combination was calculated as shown in Tables 108 to 115 below.
[0601] [Table 108]
[0602] by oregano oil combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0603]
[0604] [Table 109]
[0605] by nootkaton(+) combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0606]
[0607] [Table 110]
[0608] by spearmint oil combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0609]
[0610] [Table 111]
[0611] by rosemary oil combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0612]
[0613] [Table 112]
[0614] by thyme oil combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0615]
[0616] [Table 113]
[0617] by salanine in combination with various exemplary unsaturated aliphatic acids Botrytis CinereaGrowth inhibition
[0618]
[0619] [Table 114]
[0620] by caranza oil flavonoid extract combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0621]
[0622] [Table 115]
[0623] by neem oil limonoid extracts combined with various exemplary unsaturated aliphatic acids Botrytis Cinerea Growth inhibition
[0624]
[0625] Example 20 : by chlorfenapyr (active ingredient of Phylon® insecticide) in combination with various exemplary unsaturated aliphatic acids (and their agronomically acceptable salts). Trichoplushia ni In vitro insecticidal efficacy regarding
[0626] Sample manufacturing:
[0627] Chlorfenapyr, a pyrrole synthetic acaricide-insecticide, is the active ingredient of Pylon® insecticide (available from BASF Corp., Research Triangle Park, North Carolina, USA) and is present at 21.4% w / w in the Pylon® liquid formulation. The Pylon® liquid formulation was diluted in water to form a 2 mg / mL Pylon® mother liquor (containing 0.428 mg / mL of chlorfenapyr).
[0628] Mother solutions for trans-2-hexenoic acid and trans-3-hexenoic acid (both available from Sigma-Aldrich, St. Louis, Missouri, USA) were prepared by dissolving each exemplary unsaturated aliphatic acid in 100% dimethyl sulfoxide (DMSO) at a concentration of 20 mg / mL (20,000 ppm). A mother solution for the potassium salt of (2E,4E)-2,4-hexadienoic acid was prepared by dissolving the salt in water to form a 20 mg / mL (20,000 ppm) solution.
[0629] Trichoplushia ni An artificial diet suitable for (southern silver-striped moth larvae) was prepared according to a modified McMu-ran artificial diet recipe known in the field of entomology (containing agar, casein, potassium hydroxide, alpha-cell, Wesson salt mix, sugar, roasted wheat germ, choline chloride, ascorbic acid, methyl paraben, aureomycin, flaxseed oil, and vitamin solution).
[0630] Pylon® mother liquor was diluted in 35 mL of artificial food to produce a concentration of 0.0016 mg / mL for each Pylon® treatment, and each unsaturated aliphatic acid (and salt) mother liquor was diluted in 35 mL of artificial food to concentrations of 0.05 mg / mL, 0.15 mg / mL, and 0.30 mg / mL for each unsaturated aliphatic acid (and salt) treatment, and combinations of Pylon® and each aliphatic acid (and salt) were added to artificial food at equal concentrations for each combination treatment. Subsequently, the treated artificial food was used to fill each well of a 24-well treatment plate using approximately 0.5 mL of artificial food, solidified at room temperature, and stored overnight at approximately 4°C. The next day, the newly hatched Trichoplushia niLarvae (southern silver-striped moth larvae) (hatched from eggs obtained from the Natural Resource Canada insect research facility in Sault-Ste-Marie, Ontario, Canada) were added to each well of the plate, and their viability was monitored at 72 hours and every 24 hours for a total of 144 hours (6 days) to determine the insecticidal efficacy of Pylon® treatment alone, each unsaturated aliphatic acid (and salt) alone, and each combination of Pylon® and unsaturated aliphatic acid (and salt). Each experiment included three replicates and was repeated at least three times.
[0631] The survival rates observed for larvae at each time interval for Pylon® and unsaturated aliphatic acid (and salt) treatment alone are shown in comparison to the corresponding survival rates of the combination treatment for each of the three concentrations of unsaturated aliphatic acid (and salt) in Figures 3 to 5.
[0632] The aggregate results showing the insecticidal efficacy (equivalent to 100%-(survival rate)) for each treatment are shown in Tables 116 to 118 below (corresponding to concentrations of unsaturated aliphatic acid and salt of 0.05 mg / mL, 0.15 mg / mL, and 0.30 mg / mL, respectively).
[0633] To determine synergistic effects between two or more compounds, the Colby formula (also referred to as the Abbott formula) was used in accordance with the literature [SR Colby, Calculating Synergistic and Antagonistic Responses of Herbicide Combinations, Weeds, Vol. 15, No. 1 (Jan. 1967)], which is well known in the field of agricultural experimentation. The observed efficacy ratio (1 - (survival rate)) of individual and combination treatments was used to evaluate the efficacy data in Tables 116 through 118 regarding the synergistic effects of combinations of Pylon® and exemplary unsaturated aliphatic acids (and salts). According to the Colby formula, the expected efficacy E (%) of combination treatments of compounds A and B at concentrations a and b, respectively, can be determined by evaluating the following:
[0634] E = x + y - (xy / 100); where:
[0635] x = efficacy (%) of compound A alone applied at concentration a;
[0636] y = Efficacy (%) of compound B alone applied at concentration b.
[0637] The presence and extent of synergy in combination treatments can be determined according to the Colby formula by evaluating the synergy factor, SF = (observed efficacy) / (expected efficacy). When the SF value is greater than 1, synergy is present in the observed efficacy of the combination of compounds, and there is a synergy that increases as SF increases beyond 1. When SF is less than 1, antagonism is present, and when SF is 1, the efficacy of the compounds is merely additive. Tables 116 through 118 show the synergy factors calculated according to the above Colby formula for the observed insecticidal efficacy of each combination treatment between Pylon® and exemplary unsaturated aliphatic acids (and salts) tested. As shown in Tables 116 to 118, the combination of 0.0016 mg / mL of Phylon® insecticide (equivalent to 0.00034 mg / mL of chlorfenapyr as the active ingredient) with exemplary concentrations of unsaturated aliphatic acid (and salt) between 0.05 mg / mL and 0.30 mg / mL produced a synergistic efficacy factor of 4 to 24 times compared to the expected efficacy of the individual ingredients, demonstrating strong evidence of the synergistic pesticide efficacy of the combination according to an embodiment of the present invention.
[0638] [Table 116]
[0639] Expected efficacy and observed efficacy (%) at a concentration of 0.05 mg / mL unsaturated aliphatic acid (salt)
[0640]
[0641] [Table 117]
[0642] Expected efficacy and observed efficacy (%) at a concentration of 0.15 mg / mL unsaturated aliphatic acid (salt)
[0643]
[0644] [Table 118]
[0645] Expected efficacy and observed efficacy (%) at a concentration of 0.30 mg / mL unsaturated aliphatic acid (salt)
[0646]
[0647] Example 21 : by chlorfenapyr (active ingredient of Phylon® insecticide) in combination with various exemplary unsaturated aliphatic acids (and their agronomically acceptable salts). Trichoplushia ni In-plant insecticidal efficacy regarding
[0648] Sample manufacturing:
[0649] Chlorfenapyr, a synthetic pyrrole acaricide, was provided as the active ingredient of Pylon® insecticide (available from BASF Corporation, Research Triangle Park, North Carolina, USA) and is present at 21.4% w / w in the Pylon® liquid formulation. The Pylon® liquid formulation was diluted in water to form a 0.187 mg / mL Pylon® treatment solution (containing 0.0400 mg / mL of chlorfenapyr).
[0650] A mother solution for trans-2-hexenoic acid (available from Sigma-Aldrich, St. Louis, Missouri, USA) was prepared by dissolving trans-2-hexenoic acid in 100% dimethyl sulfoxide (DMSO) at a concentration of 20 mg / mL. A mother solution for the potassium salt of (2E,4E)-2,4-hexadienoic acid was prepared by dissolving the salt in water to form a 20 mg / mL (20,000 ppm) solution. A combined treatment solution was prepared by adding each mother solution of an exemplary unsaturated aliphatic acid and salt to a Pylon® treatment solution, thereby providing a combined treatment solution having a Pylon® concentration of 0.187 mg / mL and a concentration of 0.06 mg / mL of the exemplary unsaturated aliphatic acid (or salt).
[0651] Green cabbage plants ( Brassica oleracea Variant Capitate, Danish Ballhead breed ( Brassica oleraceavar. capitate, Danish Ballhead cultivar) was grown from seeds (available from West Coast Seeds, Delta, British Columbia, Canada) in potting soil for 4 weeks in a pest-free indoor growing environment. At 4 weeks of age, 10 mL of the treatment solution was sprayed onto each cabbage plant using a hand-pump sprayer bottle and allowed to dry. After the spray of the treatment solution dried on the leaves of the cabbage plants, 15 to 30 first larvae Trichoplushia ni (Southern silver-spotted moth larvae) Larvae (hatched from eggs obtained from the Natural Resources Canada Insect Research Facility in S.S.-Saint-Marie, Ontario, Canada) were placed directly onto the leaves of each cabbage plant. The treated cabbage plants were then placed in nylon isolation tents and maintained in an indoor growing environment, allowing the larvae to feed on the plants. In the first set of cabbage plants, the larvae were allowed to feed for 48 hours, after which the number of surviving larvae was observed and the survival rate (%) was determined. In a second separate set of cabbage plants, the larvae were allowed to feed for 72 hours, after which the number of surviving larvae was observed and the survival rate (%) was determined. Each experiment was repeated at least three times.
[0652] The aggregate results representing the insecticidal efficacy (equivalent to 100% minus survival rate) for each treatment are shown in Tables 119 and 120 below (both corresponding to observation intervals of 48 and 72 hours for two sets of plants using concentrations of 0.06 mg / mL of unsaturated aliphatic acid and salt and 0.187 mg / mL of Pylon®). To determine synergy between two or more compounds, the Colby formula (also referred to as the Abbott formula) was used according to the literature [SR Colby, Calculating Synergistic and Antagonistic Responses of Herbicide Combinations, Weeds, Vol. 15, No. 1 (Jan. 1967)], which is well known in the field of agricultural experimentation, to evaluate the efficacy data in Tables 119 and 120 regarding the synergistic effects of the combination of Pylon® and exemplary unsaturated aliphatic acids (and salts), the observed insecticidal efficacy ratios of individual and combination treatments. Percentages (equivalent to 100% minus (survival rate)) were used. According to the Colby formula, the expected efficacy E (%) of the combination treatment of compounds A and B at concentrations a and b, respectively, can be determined by evaluating the following:
[0653] E = x + y - (xy / 100); where:
[0654] x = efficacy (%) of compound A alone applied at concentration a;
[0655] y = Efficacy (%) of compound B alone applied at concentration b.
[0656] The presence and extent of synergy in combination treatments can be determined according to the Colby formula by evaluating the synergy factor, SF = (observed efficacy) / (expected efficacy). When the SF value is greater than 1, synergistic efficacy is present in the observed efficacy of the combination of compounds, and there is a synergy that increases as SF increases beyond 1. When SF is less than 1, antagonism is present, and when SF is 1, the efficacy of the compounds is merely additive. Tables 119 and 120 show the synergy factors calculated according to the above Colby formula for the observed insecticidal efficacy of each combination treatment between Pylon® and exemplary unsaturated aliphatic acids (and salts) tested. As shown in Tables 119 and 120, the combination of 0.187 mg / mL of Phylon® insecticide (equivalent to 0.0400 mg / mL of chlorfenapyr as the active ingredient) with an exemplary concentration of 0.06 mg / mL of unsaturated aliphatic acid (and salt) produced a synergistic efficacy factor of 1.14 to 1.25 relative to the expected efficacy of the individual ingredients, thereby demonstrating evidence of the synergistic pesticide efficacy of the combination according to an embodiment of the present invention.
[0657] [Table 119]
[0658] At concentrations of 0.187 mg / mL Phylon® and 0.06 mg / mL exemplary unsaturated aliphatic acid (and salt), after 48 hours, Trichoplushia ni Expected and observed in-plant efficacy (%) for
[0659]
[0660] [Table 120]
[0661] At concentrations of 0.187 mg / mL Phylon® and 0.06 mg / mL exemplary unsaturated aliphatic acid (and salt), after 72 hours, Trichoplushia ni Expected and observed in-plant efficacy (%) for
[0662]
[0663] In some embodiments according to the present disclosure, and as illustrated in some exemplary embodiments of the experimental examples described above, a combination of a C6-C10 unsaturated aliphatic acid (and an agronomically acceptable salt thereof in some specific embodiments) and a pesticide active ingredient produces a synergistic pesticide composition exhibiting a synergistic effect. That is, when used in combination, the C6-C10 unsaturated aliphatic acid and the pesticide active ingredient have greater efficacy than would be expected by simply adding the efficacy of the pesticide active ingredient and the C6-C10 unsaturated aliphatic acid when used alone. In some alternative embodiments, the unsaturated aliphatic acid or an agronomically acceptable salt thereof may comprise a C11 unsaturated aliphatic acid or an agronomically acceptable salt thereof. In some further alternative embodiments, the unsaturated aliphatic acid or an agronomically acceptable salt thereof may comprise a C12 unsaturated aliphatic acid or an agronomically acceptable salt thereof.
[0664] In some embodiments according to the present disclosure, and as illustrated in some exemplary embodiments of the experimental examples described above, a combination of a C6-C10 saturated aliphatic acid (and an agriculturally acceptable salt thereof in some specific embodiments) and a pesticide active ingredient produces a synergistic pesticide composition exhibiting a synergistic effect. That is, when used in combination, the C6-C10 saturated aliphatic acid and the pesticide active ingredient have greater efficacy than would be expected by simply adding the efficacy of the pesticide active ingredient and the C6-C10 saturated aliphatic acid when used alone. In some specific embodiments, a combination of a C6-C10 saturated aliphatic acid and a neem seed, kernel, oil, extract, or derivative pesticide active ingredient produces a synergistic pesticide composition exhibiting a synergistic pesticide effect. In some additional embodiments, a combination of a C11 or C12 saturated aliphatic acid and a neem seed, kernel, oil, extract, or derivative pesticide active ingredient produces a synergistic pesticide composition exhibiting a synergistic pesticide effect. In some alternative embodiments according to the present disclosure, a combination of a C11 or C12 saturated aliphatic acid (and an agriculturally acceptable salt thereof in some specific embodiments) and a pesticide active ingredient produces a synergistic pesticide composition exhibiting a synergistic effect.
[0665] The aforementioned examples using representative fungal and insect species demonstrate that a significant number of C6-C10 saturated and unsaturated aliphatic acids, including C6, C7, C8, C9, and C10 as well as C11 and C12 saturated and unsaturated aliphatic acids, have a synergistic effect when used in combination with insecticides or fungicidal active agents. Based on the aforementioned results and the fact that the cell membranes of eukaryotic cells share a similar lipid bilayer structure, it can be reasonably predicted that C6-C10 saturated and unsaturated aliphatic acids, as well as C11 and C12 saturated and unsaturated aliphatic acids, will have a synergistic effect when used in combination with active ingredients that control target pests, including fungi, insects, mites, mollusks, bacteria, and nematodes, which include fungicidal, insecticide, acaricide, mollusk-killing, bactericidal, and nematode active agents.
[0666] Although numerous exemplary modes and embodiments have been discussed above, those skilled in the art will recognize certain variations, substitutions, additions, and sub-combinations thereof. Accordingly, the following appended claims and subsequent claims are intended to provide the broadest possible interpretation consistent with the entire disclosure.
Claims
Claim 1 A synergistic pesticide composition comprising a pesticide active ingredient; and a C6-C10 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof, wherein the pesticide active ingredient comprises a pesticide active ingredient selected from the group consisting of pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, cyprodinil, difenoconazole, tebuconazole, epoxyconazole, propiconazole, metalaxyl, chlorfenapyr, garlic oil, wintergreen oil, peppermint oil, spearmint oil, tea tree oil, rosemary oil, nootcarton(+), neem oil, neem limonoid extract, caranza oil, caranza flavonoid extract, azadirachtin, and salanine, or a combination thereof, and wherein the C6-C10 saturated or unsaturated aliphatic acid comprises hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, trans-2-hexenoic acid, A synergistic pesticide composition selected from the group consisting of trans-3-hexenic acid, cis-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-heptene acid, trans-2-octenic acid, trans-3-octenic acid, 3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, 3-decenenic acid, 9-decenenic acid, trans-2-decenenic acid, and cis-2-decenenic acid, wherein the pesticide composition comprises the pesticide active ingredient at a pesticide-effective concentration, and the pesticide composition is a fungicide composition, an insecticide composition, a mite composition, or a nematicide composition. Claim 2 The synergistic pesticide composition according to claim 1, having an FIC index value of less than 1; or less than 0.75; or less than 0.
5. Claim 3 In claim 1, the composition is a synergistic pesticide composition that exhibits synergistic inhibition of the growth of at least one target pest organism. Claim 4 In claim 1, the composition comprises the pesticide active ingredient at a pesticide-effective concentration and the C6-C10 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof, a synergistic pesticide composition. Claim 5 In claim 1, the synergistic pesticide composition wherein the pesticide active ingredient and the C6-C10 saturated or unsaturated aliphatic acid are any one of the following: fludioxonil and hexanoic acid, octanoic acid, or decanoic acid; neem oil and octanoic acid or decanoic acid; azadirachtin and octanoic acid or decanoic acid; pyraclostrobin and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; azoxystrobin and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; chlorothalonyl and heptanoic acid, octanoic acid, or nonanoic acid; diphenoconazole and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; tebuconazole and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; propiconazole and decanoic acid; epoxyconazole and heptanoic acid, Octanoic acid, or decanoic acid; cyprodinyl and decanoic acid; metalaxyl and octanoic acid, or decanoic acid; garlic oil and hexanoic acid, octanoic acid, or nonanoic acid; wintergreen oil and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; peppermint oil and hexanoic acid, heptanoic acid, octanoic acid, or nonanoic acid; spearmint oil and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; tea tree oil and decanoic acid; nootkatone(+) and heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; rosemary oil and hexanoic acid, heptanoic acid, octanoic acid, or decanoic acid; salanine and octanoic acid or decanoic acid; caranza oil and octanoic acid, nonanoic acid, or decanoic acid; pyraclostrobin and trans-2-hexenoic acid, trans-3-hexenoic acid, Cis-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-hepteneate, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, cis-2-decenenic acid, 3-decenenic acid, or 9-decenenic acid; azoxystrobin and trans-2-hexenic acid, trans-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, 3-decenenic acid, or 9-decenenic acid;Fludioxonil and trans-2-hexenic acid, trans-3-hexenic acid, 3-hepteneate, trans-2-octenic acid, 3-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, 9-decenenic acid, or 3-decenenic acid; cyprodinyl and 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, 3-decenenic acid, or 9-decenenic acid; metalaxyl and 3-nonenenic acid, or 9-decenenic acid; diphenoconazole and trans-3-hexenic acid, 4-hexenic acid, 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, 3-nonenenic acid, trans-2-nonenenic acid, Trans-2-decenoic acid, 3-decenoic acid, or 9-decenoic acid; epoxyconazole and trans-3-hexenic acid, 3-hepteneic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, trans-2-noneneic acid, 3-noneneic acid, trans-2-decenoic acid, 3-decenoic acid, or 9-decenoic acid; tebuconazole and trans-3-hexenic acid, 5-hexenic acid, 3-hepteneic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, trans-2-noneneic acid, 3-noneneic acid, trans-2-decenoic acid, 3-decenoic acid, or 9-decenoic acid; propiconazole and 3-hepteneic acid, trans-2-noneneic acid, trans-2-decenoic acid, or 9-decenoic acid; chlorothalonil and Trans-2-nonenenic acid, 3-nonenenic acid, or 9-decenoic acid; neem oil and 3-octenic acid, trans-2-octenic acid, or 9-decenoic acid; azadirachtin and 3-octenic acid, or trans-2-octenic acid; garlic oil and trans-3-hexenic acid, 4-hexenic acid, 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, 7-octenic acid, 3-nonenenic acid, trans-2-decenoic acid, or 9-decenoic acid; wintergreen oil and trans-3-hexenic acid, trans-2-octenic acid, 9-decenoic acid, or 3-decenoic acid; peppermint oil and trans-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-octenic acid, 3-nonenenic acid, 3-decenoic acid, or 9-decenoic acid; spearmint oil and Trans-2-hexenic acid, trans-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-heptenenic acid, trans-2-octenenic acid, 3-octenenic acid, 7-octenenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, 3-decenenic acid, or 9-decenenic acid;Tea tree oil and trans-3-hexenic acid; rosemary oil and trans-3-hexenic acid, 4-hexenic acid, trans-2-octenic acid, 3-decenoic acid, or 9-decenoic acid; nuthkatone(+) and 3-decenoic acid, trans-2-decenoic acid, or 9-decenoic acid; salanine and 9-decenoic acid; caranja oil and trans-2-decenoic acid, or 9-decenoic acid; or chlorfenapyr and trans-2-hexenic acid, or trans-3-hexenic acid.; Claim 6 In claim 1, the weight ratio of the concentrations of the pesticide active ingredient and the C6-C10 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof is 1:10,000 to 10,000:1, 1:5000 to 5000:1, 1:2500 to 2500:1, 1:1500 to 1500:1, 1:1000 to 1000:1, 1:750 to 750:1, 1:500 to 500:1, 1:400 to 400:1, 1:300 to 300:1, 1:250 to 250:1, 1:200 to 200:1, 1:150 to 150:1, 1:100 to 100:1, 1:90 to A synergistic pesticide composition comprising at least one of 90:1, 1:80 to 80:1, 1:70 to 70:1, 1:60 to 60:1, 1:50 to 50:1, 1:40 to 40:1, 1:30 to 30:1, 1:25 to 25:1, 1:20 to 20:1, 1:15 to 15:1, 1:10 to 10:1, 1:9 to 9:1, 1:8 to 8:1, 1:7 to 7:1, 1:6 to 6:1, 1:5 to 5:1, 1:4 to 4:1, 1:3 to 3:1, 1:2 to 2:1, 1:1.5 to 1.5:1, and 1:1.25 to 1.25:
1. Claim 7 A synergistic pesticide composition according to claim 1, wherein the pesticide active ingredient comprises at least one pesticide-containing natural oil selected from a list including garlic oil, wintergreen oil, peppermint oil, spearmint oil, tea tree oil, rosemary oil, nootcarton(+), neem limonoid extract, caranza flavonoid extract, azadirachtin and salanin, or a combination thereof. Claim 8 A method for synergistically enhancing the activity of at least one pesticide active ingredient suitable for controlling at least one target pest organism, the method comprising: providing at least one pesticide active ingredient that is active against said at least one target pest organism; and providing a synergistic pesticide composition by adding at least one C6-C10 saturated or unsaturated aliphatic acid, or an agriculturally acceptable salt thereof, to said pesticide active ingredient. and the method comprises the step of controlling at least one target pest organism by applying the synergistic pesticide composition at a pesticide-effective concentration, wherein the at least one pesticide active ingredient is selected from the group consisting of pyraclostrobin, azoxystrobin, chlorothalonil, fludioxonil, cyprodinil, difenoconazole, tebuconazole, epoxyconazole, propiconazole, metalaxyl, chlorfenapyr, garlic oil, wintergreen oil, peppermint oil, spearmint oil, tea tree oil, rosemary oil, nootkaton(+), neem oil, neem limonoid extract, caranza oil, caranza flavonoid extract, azadirachtin, and salanine, or a combination thereof, and the C6-C10 saturated or unsaturated aliphatic acid is hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, trans-2-hexenic acid, trans-3-hexenic acid, cis-3-hexenic acid, A method comprising selecting from the group consisting of 4-hexenic acid, 5-hexenic acid, 3-heptene acid, trans-2-octenic acid, trans-3-octenic acid, 3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, 3-decenenic acid, 9-decenenic acid, trans-2-decenenic acid, and cis-2-decenenic acid, wherein the synergistic pesticide composition is a fungicide composition, an insecticide composition, a mite composition, or a nematicide composition having fungicidal, insecticidal, mite-killing, or nematicidal activity, respectively. Claim 9 In claim 8, the weight ratio of the synergistically effective concentrations of the pesticide active ingredient and the C6-C10 saturated or unsaturated aliphatic acid or an agriculturally suitable salt thereof is 1:10,000 to 10,000:1, 1:5000 to 5000:1, 1:2500 to 2500:1, 1:1500 to 1500:1, 1:1000 to 1000:1, 1:750 to 750:1, 1:500 to 500:1, 1:400 to 400:1, 1:300 to 300:1, 1:250 to 250:1, 1:200 to 200:1, 1:150 to 150:1, 1:100 to 100:1, 1:90 to A method comprising at least one of 90:1, 1:80 to 80:1, 1:70 to 70:1, 1:60 to 60:1, 1:50 to 50:1, 1:40 to 40:1, 1:30 to 30:1, 1:25 to 25:1, 1:20 to 20:1, 1:15 to 15:1, 1:10 to 10:1, 1:9 to 9:1, 1:8 to 8:1, 1:7 to 7:1, 1:6 to 6:1, 1:5 to 5:1, 1:4 to 4:1, 1:3 to 3:1, 1:2 to 2:1, 1:1.5 to 1.5:1, and 1:1.25 to 1.25:
1. Claim 10 In claim 8, the method wherein the synergistic pesticide composition has an FIC index value of less than 1; or less than 0.75; or less than 0.
5. Claim 11 In claim 8, the pesticide active ingredient and the C6-C10 saturated or unsaturated aliphatic acid are any one of the following: fludioxonil and hexanoic acid, octanoic acid, or decanoic acid; neem oil and octanoic acid or decanoic acid; azadirachtin and octanoic acid or decanoic acid; pyraclostrobin and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; azoxystrobin and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; chlorothalonyl and heptanoic acid, octanoic acid, or nonanoic acid; diphenoconazole and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; tebuconazole and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; propiconazole and decanoic acid; epoxyconazole and heptanoic acid, octanoic acid, or Decanoic acid; cyprodinyl and decanoic acid; metalaxyl and octanoic acid, or decanoic acid; garlic oil and hexanoic acid, octanoic acid, or nonanoic acid; wintergreen oil and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; peppermint oil and hexanoic acid, heptanoic acid, octanoic acid, or nonanoic acid; spearmint oil and hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; tea tree oil and decanoic acid; nootkatone(+) and heptanoic acid, octanoic acid, nonanoic acid, or decanoic acid; rosemary oil and hexanoic acid, heptanoic acid, octanoic acid, or decanoic acid; salanine and octanoic acid or decanoic acid; caranja oil and octanoic acid, nonanoic acid, or decanoic acid; pyraclostrobin and trans-2-hexenoic acid, trans-3-hexenoic acid, cis-3-hexenoic acid, 4-hexenic acid, 5-hexenic acid, 3-hepteneate, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, cis-2-decenenic acid, 3-decenenic acid, or 9-decenenic acid; azoxystrobin and trans-2-hexenic acid, trans-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, 3-decenenic acid, or 9-decenenic acid;Fludioxonil and trans-2-hexenic acid, trans-3-hexenic acid, 3-hepteneate, trans-2-octenic acid, 3-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, 9-decenenic acid, or 3-decenenic acid; cyprodinyl and 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, 7-octenic acid, trans-2-nonenenic acid, 3-nonenenic acid, 3-decenenic acid, or 9-decenenic acid; metalaxyl and 3-nonenenic acid, or 9-decenenic acid; diphenoconazole and trans-3-hexenic acid, 4-hexenic acid, 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, 3-nonenenic acid, trans-2-nonenenic acid, Trans-2-decenoic acid, 3-decenoic acid, or 9-decenoic acid; epoxyconazole and trans-3-hexenic acid, 3-hepteneic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, trans-2-noneneic acid, 3-noneneic acid, trans-2-decenoic acid, 3-decenoic acid, or 9-decenoic acid; tebuconazole and trans-3-hexenic acid, 5-hexenic acid, 3-hepteneic acid, trans-2-octenic acid, 3-octenic acid, trans-3-octenic acid, 7-octenic acid, trans-2-noneneic acid, 3-noneneic acid, trans-2-decenoic acid, 3-decenoic acid, or 9-decenoic acid; propiconazole and 3-hepteneic acid, trans-2-noneneic acid, trans-2-decenoic acid, or 9-decenoic acid; chlorothalonil and Trans-2-nonenenic acid, 3-nonenenic acid, or 9-decenoic acid; neem oil and 3-octenic acid, trans-2-octenic acid, or 9-decenoic acid; azadirachtin and 3-octenic acid, or trans-2-octenic acid; garlic oil and trans-3-hexenic acid, 4-hexenic acid, 3-heptenenic acid, trans-2-octenic acid, 3-octenic acid, 7-octenic acid, 3-nonenenic acid, trans-2-decenoic acid, or 9-decenoic acid; wintergreen oil and trans-3-hexenic acid, trans-2-octenic acid, 9-decenoic acid, or 3-decenoic acid; peppermint oil and trans-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-octenic acid, 3-nonenenic acid, 3-decenoic acid, or 9-decenoic acid; spearmint oil and Trans-2-hexenic acid, trans-3-hexenic acid, 4-hexenic acid, 5-hexenic acid, 3-heptenenic acid, trans-2-octenenic acid, 3-octenenic acid, 7-octenenic acid, trans-2-nonenenic acid, 3-nonenenic acid, trans-2-decenenic acid, 3-decenenic acid, or 9-decenenic acid;Tea tree oil and trans-3-hexenic acid; rosemary oil and trans-3-hexenic acid, 4-hexenic acid, trans-2-octenic acid, 3-decenoic acid, or 9-decenoic acid; nuthkatone(+) and 3-decenoic acid, trans-2-decenoic acid, or 9-decenoic acid; salanine and 9-decenoic acid; caranja oil and trans-2-decenoic acid, or 9-decenoic acid; or chlorfenapyr and trans-2-hexenic acid, or trans-3-hexenic acid.; Claim 12 A method according to claim 8, further comprising, prior to the step of applying the synergistic pesticide composition, a step of mixing at least one formulation component including a surfactant with the synergistic pesticide composition to form a synergistic pesticide concentrate; and a step of diluting the synergistic pesticide concentrate with water to form a synergistic pesticide emulsion. Claim 13 delete Claim 14 A synergistic pesticide composition according to claim 1, wherein the pesticide active ingredient has one or more of the following modes of action: a mode of action dependent on interaction with a cell membrane; a mode of action dependent on interaction with a cytochrome complex; a mode of action dependent on interaction with a target site inside the cell or on an intracellular organelle of a target pest; and a mode of action dependent on interaction with a target site across the cell membrane of a target pest. Claim 15 delete
Citation Information
Patent Citations
Antiseptic system
JP1994279208A
New composition having anticandidal activity
JP2013040156A
Harmful organism controlling composition for agriculture and horticulture
JP2001064104A
Antisapstain composition comprising a haloalkynyl compound, azole, and unsaturated acid.
JP2011522786A
Seed germination suppression composition
JP2015193568A
